Abstract
Conformational variations in α-syn fibrils are thought to underlie the distinct clinical features of synucleinopathies, including Lewy body dementia (LBD), Parkinson’s disease (PD), and multiple system atrophy (MSA), suggesting that distinct fibril structures act as molecular fingerprints linked to disease phenotypes. While the origins of these conformational variations remain unclear, increasing evidence points to membranes as key modulators of fibril conformations. In this study, we investigated how age-related alterations in membrane composition and fluidity influence α-syn fibril formation and cellular outcomes. Using complex membrane mixtures that mimic normal neuronal membranes and their age-related modifications in fatty acid chains, we found that α-syn fibrils grown with these membranes displayed distinct 2D ssNMR spectral patterns compared to lipid-free α-syn fibrils, reflecting differences in the rigid fibril cores. Moreover, fibrils grown with age-related membranes exhibited weaker membrane association than those formed with normal neuronal membranes. These membrane-associated fibrils induce stronger neuronal pathologies than lipid-free fibrils, although the severity differed in terms of intraneuronal aggregation and inflammatory responses. Overall, our findings provide new insights into how age-related changes in membrane composition shape α-syn fibril structure and pathogenicity, strengthening the link between membrane dynamics and amyloid-driven neurodegeneration.
Keywords: α-synuclein aggregation, synucleinopathies, fibril polymorphism, membranes, neuronal pathology, solid-state NMR


Introduction
The aggregation of misfolded α-synuclein (α-syn), characterized by its transition from a native conformation to β-sheet-rich amyloid fibrils, constitutes the primary component of cytoplasmic inclusions known as Lewy bodies (LBs). , These LBs are key pathological hallmarks of synucleinopathies, including Parkinson’s disease (PD), Lewy body dementias (LBD), and multiple system atrophy (MSA). − While synucleinopathies are typically classified based on clinical symptoms, the distribution of α-syn aggregates, and the affected cell types, growing research suggests that distinct α-syn fibril conformations are closely associated with specific synucleinopathies and contribute to their heterogeneous pathological features. − Nevertheless, the precise molecular mechanisms underlying α-syn fibril polymorphisms and their impact on synucleinopathy variability remain largely unknown.
α-Syn fibril formation is significantly influenced by multiple factors, including α-syn concentration, , temperature, − and interactions with small molecules such as RNA, DNA, and lipids. − These factors have been shown to modulate the structural characteristics of α-syn fibrils. Among them, lipids are recognized as key regulators of α-syn aggregation due to their strong interactions with α-syn in both physiological and pathological contexts. − In its native state, α-syn exists as a monomer and plays a crucial role in neurotransmitter release, particularly through its involvement in synaptic vesicle trafficking and fusion. − During these processes, α-syn is proposed to interact dynamically with various cellular membranes, including the neuronal plasma membrane and synaptic vesicles. , However, pathological conditions may alter lipid-α-syn interactions, contributing to LB accumulation. Because LBs are composed largely of lipids together with α-syn aggregates, lipid interactions may catalyze the aggregation process, disrupt membrane structure, and promote co-aggregation. Consequently, lipids are increasingly recognized as significant factors in modulating α-syn aggregation and its associated neurotoxicity.
Numerous studies have demonstrated that lipids modulate both the kinetics and conformation of α-syn fibrils. ,− For example, α-syn amyloid fibril formation is accelerated in the presence of anionic phospholipids such as phosphatidylglycerol (PG), phosphatidylserine (PS), or phosphatidic acid (PA) at relatively low lipid-to-protein (L/P) ratios. ,− This enhancement is attributed to electrostatic interactions that increase α-syn binding to membrane surfaces, thereby elevating the local α-syn monomer concentration and facilitating fibril nucleation. In contrast, binding to zwitterionic lipid vesicles composed of phosphatidylcholine (PC) either inhibits fibril formation or has minimal effect across various L/P ratios. ,, Beyond modulating fibril formation kinetics, membranes also influence α-syn fibril structures, as revealed by atomic force microscopy infrared (AFM-IR) spectroscopy, solid-state NMR (ssNMR), and cryo-electron microscopy (cryo-EM). − Collectively, these studies highlight the critical role of lipid membranes in modulating α-syn amyloid formation.
However, despite these insights, most studies have relied on simplified membrane models containing only one or two lipid types, which do not fully recapitulate the complexity of neuronal membranes. Neuronal plasma membranes are primarily composed of multiple classes of phospholipids, cholesterol, and sphingolipids. , These complex lipid environments are essential for maintaining membrane integrity and regulating cellular function through interactions with diverse biomolecules. Aging, however, disrupts the lipid balance of neuronal membranesmost notably through a decline in polyunsaturated fatty acids (PUFAs) and an increase in monounsaturated fatty acids. − Such age-related lipid alterations reduce membrane fluidity, which may, in turn, affect α-syn membrane binding affinity and aggregation behavior, potentially influencing pathological outcomes. Yet, the impact of fatty acid-driven changes in membrane properties on α-syn aggregation and its subsequent neurotoxicity remains largely unexplored. Addressing this gap requires comprehensive structural and functional studies of α-syn fibrils formed in the presence of physiologically relevant plasma membranes representing both normal and aged conditions.
In this study, we investigated how membrane composition, particularly age-related changes in fatty acid saturation, affects α-syn aggregation. To this end, we developed two model membranes representing the plasma membranes of normal and aged neurons, referred to as Neuron and Aged membranes, respectively. Both membrane models were composed of PC, phosphatidylethanolamine (PE), cholesterol, and sphingomyelin (SM) at a simplified molar ratio of 35:20:35:10. This composition was based on reported lipid abundances in neuronal plasma membranes and lipid profiling from brain tissue. , For the Neuron membranes, we selected 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC, 16:0/18:1) and 2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE, 18:1) to reflect the predominant fatty acid chain lengths and degrees of unsaturation commonly found in neuronal membranes. ,, To model age-associated changes, the Aged membranes was designed with reduced lipid unsaturation: PC was modified from POPC (16:0/18:1) to 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC, 16:0), and PE was modified from DOPE (18:1) to 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE, 16:0/18:1), reflecting reported decreases in lipid unsaturation during aging. ,,
We then characterized α-syn fibril formation in the presence of Neuron and Aged membranes. Our results demonstrate that both membranes facilitate fibril formation, with the extent of acceleration depending on the L/P ratios. Moreover, each membrane environment generates distinct fibril structures with different membrane associations. Importantly, these structural differences in α-syn fibrils drive distinct intraneuronal aggregation patterns, neurodegeneration, and inflammatory responses, providing insight into how membrane composition contributes to the conformation-dependent pathological effects of α-syn fibrils.
Materials and Methods
Protein Expression
Recombinant full-length α-syn was expressed in Escherichia coli (E. coli) BL21 (DE3) competent cells. A single colony was inoculated into 10 mL of Luria–Bertani (LB) medium containing ampicillin (100 μg/mL) and incubated overnight at 37 °C with shaking at 150 rpm. The next day, the 10 mL culture was transferred into 1 L of LB medium containing ampicillin (100 μg/mL) and incubated at 37 °C with shaking at 250 rpm until the optical density at 600 nm (OD600) reached 0.7–0.9. Protein expression was then induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG). After 4 h, cells were harvested by centrifugation at 7,000 rpm for 20 min and stored at −80 °C.
Purification of α-syn Protein
The cell pellet obtained from 1 L of culture was resuspended in 25 mL of lysis buffer (10 mM Tris, pH 8, 1 mM EDTA, 1 mM PMSF, and half of a SigmaFast protease inhibitor cocktail tablet). After transferring the resuspended cells into a centrifuge tube, lysozyme (final concentration 0.2 mg/mL) was added, and the mixture was incubated on ice for 20–30 min.
Cells were lysed by sonication at pulse rate of 10 s of on-time and 15 s of off-time, with 40% amplitude power for a total on-time of 3.5 min using a Branson Digital Sonifier SFX 250. The lysate was incubated on ice for 10–15 min, followed by centrifugation at 16,000 rpm for 1 h at 4 °C.
To maximize purity and yield, an acid precipitation method was adapted. The milky supernatant was transferred to clean 25 mL centrifuge tubes, and the pH was adjusted to 3.5. After stirring at room temperature for 20 min, sample were centrifuged at 16,000 rpm for 30 min at 4 °C, resulting in a clear supernatant. The pH was then adjusted back to 7.5 before an additional centrifugation step at 16,000 rpm for 1 h at 4 °C to remove residual aggregates.
The collected supernatant was filtered through a PVDF syringe filter with 0.45 μm pore size (Avantor, VWR Syringe Filters) and dialyzed overnight at 4 °C against 1 L of low-salt anionic-exchange buffer (10 mM Tris, pH 7.6, 25 mM NaCl, 1 mM EDTA) using a dialysis membrane with a molecular weight cutoff (MWCO) of 3.5 kDa (Spectrum Laboratories, Inc., Spectra/Por3 Dialysis Membrane).
The following day, the dialyzed α-syn sample was filtered through a PES syringe filter with 0.22 μm pore size (Avantor, VWR Syringe Filters) and loaded onto a double-stacked prepacked HiTrap Q Sepharose High Performance anion-exchange chromatography column (Cytiva Sweden AB, #17115401). The column was washed with Buffer A (10 mM Tris, pH 7.6, 25 mM NaCl, 1 mM EDTA) and Buffer B (10 mM Tris, pH 7.6, 1 M NaCl, 1 mM EDTA). α-Syn-containing fractions were pooled at a conductivity of 30 mS/cm and concentrated to approximately 13 mg/mL using a 10 kDa Amicon Ultra centrifugal filter device (Millipore).
The concentrated protein was then loaded onto a prepacked HiPrep 16/60 Sephacryl S-200 High Resolution preparative size-exclusion chromatography column (Cytiva Sweden AB, #17116601). Size-exclusion chromatography was performed using buffer containing 10 mM Tris (pH 7.6) and 100 mM NaCl with a total column volume of 126 mL. α-Syn protein eluted between 40 and 60 mL. All chromatography steps were performed using an AKTA pure system (GE Healthcare Bio-Sciences AB, Sweden). Protein concentration was determined using a NanoDrop ND-1000 UV/vis Spectrophotometer (Thermo Fisher Scientific), and purity was assessed by SDS-PAGE gel electrophoresis. Purified α-syn was dialyzed against 1 L of distilled water overnight at 4 °C and stored at −80 °C.
Lipid Vesicle Solution
To mimic physiologically relevant normal and aged neuronal membranes, 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), cholesterol, and sphingomyelin (SM) were purchased from Avanti Polar Lipids.
The Neuron membrane model consisted of POPC:DOPE:cholesterol:SM at a molar ratio of 35:20:35:10, while the Aged membrane model consisted of DPPC:POPE:cholesterol:SM at the same molar ratio. These compositions were selected to reflect the lipid abundance of normal neuronal membranes as well as age-associated changes in fatty acid saturation. ,,,
To prepare these membranes, phospholipids, cholesterol, and SM were codissolved in a chloroform/methanol mixture, and solvents were evaporated under a stream of N2 gas. Lipid films were vacuum-desiccated overnight, rehydrated in 12 mM Tris-HCl buffer (pH 7.6) to a total lipid concentration of 12.5 mM, and briefly sonicated for 10–15 s. Samples then underwent ten freeze–thaw cycles using liquid nitrogen and a 50 °C water bath to produce homogeneous vesicles. The resulting 12.5 mM vesicle stock was diluted to achieve the desired lipid-to-protein molar (L/P) ratio.
Fibril and PFF Formation
Fibrils were generated by incubating 200 μM α-syn in 10 mM Tris-HCl buffer (pH 7.6) for 4 weeks at 37 °C without agitation, either in the absence or presence of lipid vesicle solutions at L/P ratios of 5, 10, and 50.
Preformed fibrils (PFFs) were generated by sonicating fibrils prepared at L/P = 0 or 10 using a sonifier (Branson Digital Sonifier SFX 250 with Sonifier Sound Enclosure) at a pulse rate of 1s of on-time and 4 s of off-time, 10% amplitude power, and total on-time of 2 min. The average PFF length (∼100 nm) was confirmed by negatively stained transmission electron microscopy (Figure S9). PFFs generated from α-syn fibrils grown in the absence of membranes or in the presence of Neuron or Aged membranes are referred PFFs, N-PFFs, and Aged-PFFs, respectively. All prepared PFFs were stored at −80 °C and thawed and bath-sonicated for 1 min immediately before use.
To control for lipid-associated contributions in N-PFFs and Aged-PFFs, lipid-free PFFs were mixed with Neuron or Aged membranes at an L/P ratio of 10, generating PFFs + N-lipid and PFFs + Aged-lipid. In parallel, α-syn monomers were combined with Neuron or Aged membranes (Mono + N-lipid and Mono + Aged-lipid).
Transmission Electron Microscopy (TEM)
Negatively stained fibrils or PFFs were prepared on lacey carbon-coated copper grids (Electron Microscopy Sciences LC-325-CU-CC, Ted Pella 01824). A 10 μL aliquot was deposited onto the grid and allowed to adsorb for 1–2 min. After absorption, the solution was blotted, washed with 10 μL of water, blotted again, and stained with 10 μL of UranyLess EM stain solution (Electron Microscopy Sciences) for 30 s. TEM images were acquired on a JEOL 2100F Field-emission transmission electron microscope at 120 kV using a Gatan Ultrascan CCD camera and DigitalMicrograph (GMS3) software (Gatan Inc.).
Thioflavin T (ThT) Fluorescence Monitoring of Fibril Formation Kinetics
ThT (25 μM) was added to freshly prepared monomeric α-syn (200 μM) in the absence or presence of Neuron or Aged membranes in 10 mM Tris-HCl buffer (pH 7.6). Measurements were performed in Greiner Bio-One 96-well microplates (655900). To prevent sample dehydration during measurements, 100 μL of distilled water was added to the outermost wells.
Fluorescence measurements were recorded on a FLUOstar Omega microplate reader (BMG LABTECH) at 37 °C with excitation at 485 nm and emission at 538 nm. Readings were collected every 30 min or 1 h with a gain setting of 800–1000. Before each measurement, the well plate was orbitally shaken at 700 rpm for 60 s. Each condition was measured in triplicate, and curves were normalized to the maximum fluorescence intensity.
Solid-State NMR (ssNMR) Sample Preparation
For ssNMR measurements, uniformly 13C, 15N-labeled α-syn protein was expressed in E. coli BL21 (DE3) competent cells. Cells were grown in 2 L of LB media containing ampicillin (100 μg/mL) at 37 °C with shaking at 250 rpm until OD600 reached 0.5–0.6. Cells were harvested by centrifugation at 7,000 rpm for 20 min, and the pellet was resuspended in 1 L of M9 medium containing 2 g of 13C-labeled glucose, 1 g of 15N-labeled ammonium chloride, 2 mM of MgSO4, 0.1 mM of CaCl2, 100 μg/mL of ampicillin, and 10 mL of Gibco 100x MEM vitamin solution (ThermoFisher Scientific). Incubation at 37 °C continued until OD600 = 0.8–0.9, at which point expression was induced with 1 mM IPTG. After 4 h, cells were collected by centrifugation at 7,000 rpm for 20 min and stored at −80 °C. Uniformly labeled 13C and 15N-labeled α-syn was purified using the same procedures as for unlabeled α-syn.
Uniformly 13C, 15N-labeled lipid-free α-syn fibrils were prepared by seeding 200 μM monomeric 13C, 15N-labeled α-syn with 5 mol % (monomer equivalent) lipid-free PFFs in 10 mM Tris-HCl buffer (pH 7.6). Uniformly 13C, 15N-labeled α-syn fibrils grown with Neuron or Aged membranes at an L/P ratio of 10 were prepared using the same procedure as for lipid-free fibrils, except that 5 mol % (monomer equivalent) N-PFFs or Aged-PFFs was added to 200 μM monomeric 13C, 15N-labeled α-syn in the presence of Neuron or Aged membranes (L/P = 10) in 10 mM Tris-HCl buffer (pH 7.6), respectively. In addition, uniformly 13C, 15N-labeled α-syn fibrils formed with Aged membranes at an L/P ratio of 50 were prepared by incubating 200 μM monomeric 13C, 15N-labeled α-syn with Aged membranes (L/P = 50) in 10 mM Tris-HCl buffer (pH 7.6) without seeding. All fibrils used for ssNMR experiments were generated at 37 °C without agitation, and fibril formation was confirmed by negatively stained TEM images.
To evaluate membrane association of lipid-free α-syn fibrils, uniformly 13C, 15N-labeled lipid-free α-syn fibrils were mixed with Neuron or Aged membranes at an L/P ratio of 10 and incubated for 24 h at 37 °C without agitation. This enabled direct comparison of membrane association between the two membrane types.
Fibrils were pelleted by centrifugation at 50,000 rpm overnight at 20 °C using a Beckman SW 60Ti rotor. Pellets were slowly dried in a desiccator to achieve 55–65% water by mass. Approximately 25–30 mg of hydrated fibrils were packed into 3.2 mm MAS rotors.
Solid-State NMR Experiments
All ssNMR experiments were conducted on an 800 MHz (18.8 T) Bruker Advance III-HD NMR spectrometer equipped with a 3.2 mm 1H–13C–15N magic angle spinning (MAS) probe (Black Fox, LLC). 13C chemical shifts are reported on the TMS scale using the 38.48 ppm CH2 signal of adamantane as a reference. 1D 13C cross-polarization (CP) and 2D 15N–13C and 13C–13C correlation spectra were measured under 13.5 kHz MAS at 275–295 K. 2D 13C–13C DARR spectra were acquired with mixing times of 50 and 100 ms. ,
To probe the extent of fibril-membrane association, 2D 13C-detected 1H–1H spin-diffusion experiments were performed on α-syn fibrils grown with Neuron or Aged membranes at 285–295 K under 13.5 kHz MAS. − A 400 μs 1H T2 filter was applied to suppress 1H magnetization of the rigid fibrils. Following 1H chemical shift evolution, 1H–1H spin diffusion mixing times ranging from 4 to 225 ms were used to transfer water and lipid 1H magnetization to the protein. The transferred magnetization was detected via 13C following 1H–13C CP.
To ensure that sample integrity was maintained throughout the ssNMR experiments, 1D 1H and 13C spectra were recorded before and after 2D ssNMR measurements.
Calcein Release Assays
The ability of α-syn to disrupt the membrane integrity of lipid vesicles was assessed using calcein release assays, following a previously established protocol. To prepare calcein-loaded lipid vesicles, freshly prepared lipid films with the normal neuronal membrane-mimetic composition (POPC:DOPE:cholesterol:SM at a molar ratio of 35:20:35:10) were hydrated with 1 mL of 100 mM calcein solution (pH 7.4) and subjected to 10 freeze–thaw cycles to facilitate calcein encapsulation. The resulting solution was extruded using a mini-extruder (Avanti Polar Lipids) through a 100 nm pore-size polycarbonate membrane (Cytiva) 15 times to generate a homogeneous population of unilamellar liposomes.
Calcein-loaded vesicles were then separated using a gravity-flow chromatography column packed with Sephadex G-50 beads. Eluted fractions containing calcein liposomes, identified by a light orange color, were collected, while darker orange fractions corresponding to free calcein dye were discarded. The purified calcein-containing liposomes were stored at 4 °C until use.
Fluorescence measurements were recorded every 10 min overnight using a FLUOstar Omega microplate reader (BMG LABTECH) with excitation at 485 nm and emission at 520 nm. All experiments were conducted at room temperature in Greiner Bio-One 96-well microplates (655900), with a total sample volume of 75 μL per well.
Membrane permeability was assessed by adding 13 μM of α-syn PFFs to purified calcein-containing liposomes. As a positive control for maximum dye release, calcein-containing liposomes were treated with 10% Triton X-100. Membrane permeability was calculated using the following equation:
where I(t) represents the fluorescence intensity at time t, I(t 0) is the initial fluorescence intensity at t = 0, and I max is the maximum fluorescence intensity measured after treatment with 10% Triton X-100.
Bicinchoninic Acid (BCA) Assay for Monomer–Membrane Binding Analysis
The concentration of membrane-bound α-syn monomers was quantified using a bicinchoninic acid (BCA) assay. Freshly prepared monomeric α-syn (200 μM), with or without Neuron or Aged membranes (L/P = 10) in 10 mM Tris-HCl buffer (pH 7.6), was vortexed 5 s and incubated quiescently at 37 °C for 4 h to allow α-syn-membrane binding. Following incubation, membrane-bound α-syn was pelleted by centrifugation at 50,000 rpm for 1 h at 4 °C.
A 20 μL of the supernatant containing unbound α-syn monomer was carefully collected for denaturation and BCA analysis. Control samples consisting of 10 mM Tris-HCl buffer, 2 mM Neuron membranes, or 2 mM Aged membranes without α-syn monomers were processed in parallel.
A six-point protein standard curve (0–200 μM α-syn monomer) was prepared in 10 mM Tris-HCl buffer (pH 7.6). A denaturing solution (0.2 M NaOH + 2% SDS) was prepared in deionized water. For each standard or sample, 20 μL of solution was mixed with 20 μL denaturing solution, vortexed briefly, heated at 95 °C for 5 min to fully denature proteins, and then cooled to room temperature.
BCA working reagent (WR) was freshly prepared by mixing BCA Reagent A and Reagent B (ThermoFisher Scientific) at a 50:1 (A:B) ratio. For each reaction, 25 μL of the denatured sample or standard was added to 200 μL of BCA WR, vortexed for 5 s, and incubated at 37 °C for 30 min. After incubation, 50 μL aliquots of each reaction were dispensed into a Greiner Bio-One 96-well microplate (655900) in quadruplicate. Absorbance at 562 nm was measured using a FLUOstar Omega microplate reader (BMG LABTECH). Readings were collected every 10 min for 40 min, with orbital shaking at 700 rpm for 60 s before each measurement. The average absorbance from four measurements was reported.
Dynamic Light Scattering (DLS) Measurements
DLS measurements were performed using a Zetasizer Nano Series Instrument (Malvern Instruments) equipped with a He–Ne laser (λ = 633 nm) and operated at a backscattering detection angle of 173°. Neuron or Aged membrane samples were prepared as described above using 10 freeze–thaw cycles, then diluted to 2 mM lipid concentration either in the absence or presence of 200 μM α-syn monomers in 10 mM Tris-HCl buffer (pH 7.6). Samples were incubated at 37 °C for 0, 2, 7, and 14 days prior to measurements.
Before measurement, samples were diluted 1:1 (v/v) with 10 mM Tris-HCl buffer (pH 7.6), then resuspended and mixed thoroughly before transfer into a disposable quartz cuvette (ZEN0040, Malvern Panalytical). All measurements were conducted at 25 °C using water as the dispersant (refractive index = 1.330; viscosity = 0.8872 cP at 25 °C). The sample viscosity was set equal to that of the dispersant. Phospholipid optical parameters were set to a refractive index of 1.450 and absorption coefficient of 0.100. For each condition, 15 runs of 10 s were recorded following a 2 min equilibrium period. Data were analyzed using Zetasizer software (Malvern Instruments) with the general-purpose analysis model.
Proteinase K Digestion
Proteinase K (PK) digestion was performed on three types of 5 mol % seeded α-syn fibril prepared in 10 mM Tris-HCl buffer (pH 7.6): lipid-free α-syn fibrils, α-syn + Neuron fibrils, and α-syn + Aged fibrils. Mature fibrils were mixed with PK to a final PK concentration of 0.05 mg/mL. After a brief 5–10 s vortex, samples were incubated at 37 °C for 2–10 min. Reactions were terminated by heating samples at 90 °C for 15 min. Samples were then cooled to room temperature and briefly centrifuged. PK-inactivated samples were snap-frozen in liquid nitrogen, lyophilized, and resuspended in 400 μL of hexafluoroisopropanol (HFIP). Samples were sonicated in a water bath for 5 min, vortexed for 30 s, and left capped in a fume hood overnight to allow complete HFIP solubilization. The following day, HIFP was evaporated under a gentle stream of N2 gas.
To remove lipid components, an acetone precipitation step was performed. Precooled acetone (−20 °C) was added at four times the sample volume, followed by vortexing for 10 s and incubated at −20 °C for 1 h. Samples were centrifuged at 13,200 rpm for 10 min, the supernatant was discarded, and residual acetone was evaporated under N2. Dried pellets were resuspended in 50 μL of denaturing buffer (8 M urea and 4% SDS), vortexed vigorously, sonicated for 1 min, and incubated at room temperature for 15 min with intermittent vortexing to ensure complete solubilization.
Protein digestion profiles were analyzed by SDS-PAGE followed by silver staining. Gels were fixed twice for 15 min in 30% ethanol:10% acetic acid, washed sequentially with 10% ethanol and distilled water, sensitized for 1 min, stained for 30 min, and developed for 30 s to 2 min until optimal band intensity was achieved. Development was stopped with 5% acetic acid for 10 min.
Cell Culture
To establish a dopaminergic neuron model, the human neuroblastoma cell line (SH-SY5Y; ATCC, CRL-2266) was selected and expanded in 25 cm2 flasks following the manufacturer’s protocols. To culture SH-SY5Y cells, Dulbecco’s Modified Eagle Medium (DMEM; 10-017-CV, Corning) was used as the basal growth medium, supplemented with 10% (v/v) heat-inactivated fetal bovine serum (hiFBS; SH30396.03, Cytiva), 1% (v/v) GlutaMAX-I (35050-06, ThermoFisher) and 1% (v/v) penicillin-streptomycin (SV30010, Cytiva). SH-SY5Y cells at passages 3 to 10 were used as recommended by the cell supplier.
The process of dopaminergic neuronal differentiation started with trypsinization and resuspension of SH-SY5Y cells in growth medium. The harvested cells were then introduced into 48-well plates at a density of 5.0 × 105 cells/mL. The initial culture was maintained in their growth medium to promote cell adherence and stabilization. Two days after seeding, the SH-SY5Y cell growth medium was replaced with the first differentiation medium consisting of DMEM supplemented with 2.5% (v/v) hiFBS, 1% (v/v) GlutaMAX-I, 1% (v/v) penicillin-streptomycin, and 10 μM retinoic acid (50-165-6969, Fisher Scientific) to induce differentiation into dopaminergic neuronal cells. After 5 days, the first differentiation medium was switched to a second differentiation medium based on Neurobasal-A (10888022, ThermoFisher) mixed with 50 ng/mL brain-derived neurotrophic factor (BDNF; P23560, FUJIFILM Irvine Scientific), 20 mM potassium chloride (KCl; 7447-40-7, Avantor Science), 1% (v/v) B27 (17-504-044, Fisher Scientific), 1% (v/v) GlutaMAX-I, and 1% (v/v) penicillin-streptomycin. The second differentiation medium was also maintained for an additional 5 days. Both the first and second differentiation media were refreshed every other day to support and sustain the dopaminergic differentiation of SH-SY5Y cells.
Treatment of Lipid-Free or Membrane-Associated α-syn PFFs
To investigate the pathological impacts of polymorphic α-syn fibrils, differentiated dopaminergic neuronal cells were exposed to different α-syn PFFs. A 200 μM stock solution of each α-syn PFFs conformer was sonicated for 15 s to ensure uniform dispersion and achieve an average fibril length of approximately ∼100 nm. For cell treatment, the sonicated PFF stock solution was diluted to a final concentration of 1 μg/mL in the second differentiation medium.
On Day 12 of culture, α-syn PFFs-containing medium was added to each well containing dopaminergic neuronal cells. The cultures were then incubated with the fibrils for 72 h. After incubation, the medium was replaced with fresh differentiation medium. Treated cells were either analyzed immediately or maintained for an additional 3 days prior to analysis.
Immunostaining and Quantification
For immunostaining, dopaminergic neuronal cells were fixed with 4% paraformaldehyde (AR1068, Boster) for 30 min at RT and washed twice using DPBS. After fixation, cells were permeabilized with 0.1% Triton X-100 (9002-93-1, VWR) for 15 min. To prevent nonspecific binding, the cells were blocked with 1.5% bovine serum albumin (BSA; 22013, Biotium) for 30 min at RT. Subsequently, the cells were incubated overnight at 4 °C with primary antibodies that selectively bind to the proteins of interest.
To visualize the actin cytoskeleton, Phalloidin-CF 430 (Biotium) was applied at 1:100 dilution. Neuronal differentiation was assessed using primary antibodies: rabbit polyclonal anti-MAP2 (A16829, 1:200, Antibodies.com) for dendritic extensions, mouse monoclonal anti-GAP43 (A85392, 1:1000, Antibodies.com) for axonal projections, and mouse monoclonal anti-β III Tubulin (A86691, 1:500, Antibodies.com) for the neuronal cytoskeleton. To confirm PD-specific misfolding of endogenous α-syn and α-syn aggregation, we used rabbit monoclonal antibodies against α-syn phosphorylated at Ser129 (A304933, 1:500, Antibodies.com) and α-syn aggregates (A209538, 1:5000, Antibodies.com), respectively. To assess the dopaminergic characteristics of neuronal cells, Tyrosine Hydroxylase (TH) expression was examined using a mouse monoclonal anti-TH antibody (A104316, 1:5000, Antibodies.com). For investigating inflammatory responses, a rabbit polyclonal anti-NF-kB antibody (51-0500, 1:500, ThermoFisher) was used.
After incubation with primary antibodies, cells were washed twice with DPBS and incubated for 1–2 h at RT with fluorescently labeled secondary antibodies (A32732, ThermoFisher; A32723, ThermoFisher; A32731, ThermoFisher; A11032, ThermoFisher). Hoechst (33342, ThermoFisher) was used for nuclear staining.
Fluorescence images of the cells were captured using a Nikon Ti2-Eclipse microscope. NF-κB and pSer129 imaging was performed with excitation and emission wavelengths of 500 and 535 nm, respectively, and α-syn fibrils labeled with MJFR-14-6-4-2 were imaged with excitation at 620 nm and emission at 700 nm. Exposure times were 900 ms for NF-κB, pSer129, and TH, and 300 ms for MJFR-14-6-4-2. Image processing was performed using NIS Elements software.
To quantitively assess the data, fluorescence intensity was averaged from three samples per condition. To account for background fluorescence due to light diffusion, background signal was measured in acellular regions and subtracted from cellular measurements, thereby correcting for diffuse light that uniformly elevates fluorescence intensity.
Statistical value of the obtained data was assessed by a two-tailed t test. Results from three independent experiments are presented as mean ± SD.
Results
α-syn Forms Fibrils in the Presence of Normal and Aged Neuronal Membranes
To model physiological conditions of neuronal membranes and their age-related alterations, we prepared two types of vesicles: Neuron membranes, representing normal neuronal plasma membranes, and Aged neuronal membranes. Neuron membranes were composed of 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), cholesterol, and sphingomyelin (SM) at a 35:20:35:10 molar ratio. To reflect the reduction in unsaturated fatty acid content and acyl chain length observed in brains with aging, Aged membranes were prepared by substituting POPC and DOPE with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), while maintaining the same molar ratios (Figure ). α-syn fibril formation was initiated by incubating 200 μM of α-syn monomers at 37 °C under quiescent conditions, either in the absence or presence of Neuron or Aged membranes at a lipid-to-protein molar (L/P) ratio of 10. Structural changes in α-syn monomers during incubation were monitored by circular dichroism (CD) spectroscopy (Figure D). Initially, α-syn monomers incubated with Neuron (green) or Aged (red) membranes exhibited α-helical-like spectra, characterized by two minima near 208 and 222 nm, consistent with previous reports showing that membrane-bound α-syn adopts a helical structure. − After 400 h of incubation without agitation, a pronounced negative peak appeared near 218 nm, indicating a transition to a β-sheet-rich conformation, a hallmark of fibril formation. These results confirm that α-syn monomers form fibrils over extended incubation periods. Fibril formation, in both the absence and presence of membranes, was also confirmed by negatively stained transmission electron microscopy (TEM) (Figure A–C).
1.
Lipid compositions of model membranes mimicking plasma membranes of normal and aged neurons, referred to as Neuron and Aged membranes in this study. (A) Lipid compositions of Neuron and Aged membranes, consisting of PC, PE, Cholesterol, and SM in a 35:20:35:10 molar ratio. (B) Chemical structures of POPC and DOPE, the primarily lipid components of the Neuron membrane. (C) Chemical structures of DPPC and POPE, which characterize the Aged membrane with altered saturation levels. Compared to POPC and DOPE in Neuron membranes, DPPC and POPE have shorter and more saturated acyl chains.
2.

Characterization of α-syn fibril formation in the absence and presence of lipid membranes. (A–C) Negatively stained TEM images confirming fibril formation after incubation: (A) α-syn fibrils formed without membranes, (B) α-syn fibrils formed in the presence of Neuron membranes, and (C) α-syn fibrils formed in the presence of Aged membranes. Scale bars: 100 nm. Orange arrows indicate lipid membranes. (D) CD spectra of α-syn in the absence (black) and presence of Neuron (green) or Aged membrane (red) over 400 h of incubation without agitation. Dotted lines represent spectra at 0 h, and solid lines indicate spectra at 400 h, revealing structural transitions from an α-helical conformation to a β-sheet-rich fibril structure.
Membranes Alter a-syn Aggregation Kinetics
Thioflavin T (ThT) fluorescence assays were used to monitor aggregation kinetics under varying protein concentrations and L/P ratios, with three replicates measured for each condition. Each fluorescence curve was normalized to its maximum intensity (Figure A–C). The t0.1 and t0.5 valuescorresponding to the times required to reach 10% and 50% of maximal ThT fluorescence intensity, respectivelywere used to quantitatively compare aggregation properties under different conditions (Figure D). These parameters are commonly referred to as the lag phase and elongation phase, reflecting monomer nucleation and subsequent conversion into amyloid forms, respectively. In the absence of lipids, accelerated fibril formation was observed at higher α-syn monomer concentrations, as evidenced by decreased t0.1 and t0.5 values (Figure D). To assess the effects of Neuron and Aged membranes on fibril formation, all subsequent experiments were conducted at a monomer concentration of 200 μM with L/P ratios of 5, 10, and 50 (Figure B,C).
3.

Effects of protein concentration and L/P ratio on α-syn aggregation kinetics. (A) ThT fluorescence curves of α-syn aggregation kinetics at monomer concentration of 200 μM (black) and 300 μM (gray) in the absence of lipid over 288 h. Higher α-syn concentrations result in shorter lag times and steeper sigmoidal curves. (B) ThT fluorescence curves of α-syn aggregation in the presence of Neuron membranes at L/P ratios of 5 (lime green), 10 (green), and 50 (dark green) over 240 h. (C) ThT fluorescence curves of α-syn aggregation in the presence of Aged membranes at L/P ratios of 5 (orange), 10 (red), and 50 (brown) over 240 h. (D) Quantitative comparison of aggregation kinetics using t0.1 (open bars) and t0.5 (solid bars), representing the times required to reach 10% and 50% of maximal ThT fluorescence intensity, respectively. The same color scheme from panels (A–C) is applied. Data show mean ± SD with n = 3. ***P < 0.001, **P < 0.01 *P < 0.05.
The presence of both Neuron and Aged membranes enhanced α-syn fibril formation at 200 μM across all L/P ratios, as indicated by significantly reduced t0.1 and t0.5 values. For Neuron membranes (Figure B), an L/P ratio of 10 yielded a shorter elongation phase compared to L/P ratios of 5 and 50, accompanied by steeper sigmoidal ThT curves. This affect is attributed to membrane surface-bound α-syn, which acts as a nucleation site, promoting aggregation at relatively low L/P ratios. However, at an L/P ratio of 50, increased α-syn binding to lipid vesicles reduces the concentration of free α-syn monomers in solution, thereby slowing fibril formation. Consistently, α-syn monomer binding assays showed higher levels of membrane-bound α-syn monomers with Neuron membranes at an L/P ratio of 50 compared to L/P ratios of 5 and 10 (Figure S6A).
In contrast, in the presence of Aged membranes (Figure C), an overall trend toward faster fibril formation was observed with higher L/P ratios. Notably, at an L/P ratio of 50, both the lag phase and elongation phase were markedly shortened (Figure D). This observation suggests that α-syn has a lower binding affinity for Aged membranes than for Neuron membranes, allowing a higher concentration of free α-syn to remain in solution and thereby facilitating fibril formation at high L/P ratios. Consistently, the lower levels of membrane-bound α-syn monomers observed with Aged membranes at L/P ratios of 5 and 50 further support this conclusion (Figure S6A).
Membrane-Induced Conformational Variations in α-syn Fibrils Revealed by Solid-State NMR
While the TEM images of the three α-syn fibril samples primarily show untwisted fibrils (Figure A–C), minor populations of twisted fibrils with distinct crossover patterns were also observed (Figure S1). These observations indicate conformational polymorphism both within and between samples, likely arising from the complex mechanisms underlying membrane-associated protein aggregation.
Protein aggregates typically consist of a protease-resistant fibrillar core surrounded by a protease-susceptible disordered region. Accordingly, proteinase K (PK) digestion is commonly used to compare structural differences among fibril strains. − To assess conformational variations among three α-syn fibrils grown either in the absence or in the presence of Neuron or Aged membranes, the fibrils were treated with PK and the resulting digestion patterns were analyzed by SDS-PAGE (Figure S2). α-Syn fibrils formed in the presence of Neuron membranes exhibit a protease-resistant core after 2 min of proteinase K (PK) digestion but are largely degraded after 10 min, as indicated by the appearance of fragments smaller than ∼11 kDa. In contrast, lipid-free fibrils and fibrils formed with Aged membranes retain PK-resistant cores even after 10 min of digestion. Notably, these two samples display distinct digestion patterns, differing in both the sizes and relative intensities of the resulting peptide fragments. Together, these results demonstrate that all three fibril preparations possess structurally distinct cores.
We next measured 2D ssNMR spectra for uniformly 13C, 15N-labeled α-syn fibrils formed either without lipids or in the presence of Neuron or Aged membranes at an L/P ratio of 10 for detailed structural comparison (Figure A–C). Fibril growth for lipid-free α-syn, α-syn + Neuron, and α-syn + Aged membrane samples was initiated by adding 5 mol % (monomer equivalent) of the corresponding short, preformed fibrils (PFFs). Specifically, three types of PFFs were generated by sonicating fibrils grown without lipids, with Neuron, or with Aged membranes, referred to as PFFs, N-PFFs, and Aged-PFFs, respectively. The resulting PFFs were approximately 100 nm in length, as confirmed by negatively stained TEM (Figure S9). Each PFF type was then added to 200 μM uniformly 13C, 15N-labeled α-syn monomers in the absence or presence of the corresponding membranes (L/P = 10).
4.
Comparison of 2D NMR spectra of α-syn fibrils grown under different conditions. (A) 2D 15N–13C (top) and 13C–13C (bottom) correlation spectra of lipid-free α-syn fibrils (black). (B) 2D 15N–13C (top) and 13C–13C correlation spectra of α-syn fibrils grown with Neuron membranes (green), overlaid with lipid-free α-syn fibrils (black). Dotted pink circles indicate peaks present only in lipid-free α-syn fibrils, while solid pink circles highlight peaks unique to α-syn fibrils grown with Neuron membranes. (C) 2D 15N–13C (top) and 13C–13C (bottom) correlation spectra of α-syn fibrils formed with Aged membranes (red), overlaid with the lipid-free α-syn fibrils (black). Dotted cyan circles indicate peaks present only in lipid-free α-syn fibrils, while solid cyan circles mark peaks exclusive to α-syn fibrils formed with Aged membranes. (D) Quantification of residue-specific Cα-Cβ cross peak intensities from the 2D 13C–13C spectra, normalized within each data set, comparing the relative amino acid composition of fibril core among lipid-free α-syn fibrils, α-syn fibrils grown with Neuron, and those grown with Aged membranes.
All ssNMR spectra were acquired under conditions optimized for ssNMR, using cross-polarization (CP) which transfers nuclear spin polarization through magnetic dipole–dipole couplings, along with high-power 1H decoupling. Under these conditions, ssNMR detects signals primarily from rigid, immobilized residues within the fibril core. −
In the 2D 15N–13C spectra, all three fibril samples exhibited most peaks with 15N chemical shifts exceeding 120 ppm, indicating β-sheet conformations. However, several distinct peaks, highlighted by pink and cyan circles, confirm membrane-induced conformational variations among the three fibrils (Figure B,C). To obtain amino-acid-specific structural information on the fibril core, we measured 2D 13C–13C correlation spectra using a dipolar coupling-based polarization transfer sequence. The 2D 13C–13C correlation spectrum of lipid-free α-syn fibrils, acquired with a 100 ms DARR mixing time, shows β-sheet chemical shifts for Thr, Val/Pro, Gln/Glu/Lys, and Ala residues, along with a small helical Thr peak and random coil peaks for Ala and Gln/Glu/Lys residues. This confirms that lipid-free α-syn fibrils adopt a β-sheet rich amyloid structure with a small, disordered region (Figure A). The 2D 13C–13C correlation spectra of α-syn fibrils grown with Neuron or Aged membranes show predominant peaks that align closely with those observed in lipid-free fibrils (Figure B,C). However, these membrane-associated fibrils lack the α-helical Thr peak observed in lipid-free fibrils and instead exhibit additional β-sheet Thr peaks. Fibrils grown with Neuron membranes show weaker coiled Gln/Glu/Lys peaks compared to the other two fibrils. These observations indicate conformational differences in the fibril core across the three fibril samples. Notably, fibrils grown with Neuron or Aged membranes display inter-residue cross peaks between Thr-Ala or Thr-Lys, despite being measured with a shorter 50 ms DARR mixing time compared to lipid-free fibrils. This observation suggests that membrane-associated fibrils adopt a more compact and rigid core structure. Considering the multiple Thr-Lys and Thr-Ala pairs in the α-syn sequence, these inter-residue correlations likely result from intramolecular interactions.
Because 2D 13C–13C correlation spectra capture signals from the rigid fibril core, the measured peak intensities reflect the relative abundance of residues present in the fibril core. All 2D 13C–13C spectra of α-syn fibrils exhibited well-resolved Cα-Cβ cross peaks for Val/Pro, Ala, Thr, and Gln/Glu/Lys residues, enabling quantitative comparison of their relative abundances. Peak intensities were obtained by integrating each corresponding cross peak and were normalized to the sum of the four peaks to allow comparison of relative contributions within each 2D 13C–13C correlation spectrum (Figure D). For lipid-free α-syn fibrils (Figure A), the normalized intensities for Val/Pro, Ala, Thr, Gln/Glu/Lys were 27%:23%:13%:37%. In contrast, α-syn fibrils grown with the Neuron membranes displayed 33%:25%:15%:27%, showing an increased Val/Pro contribution and reduced Gln/Glu/Lys contribution. Fibrils grown with Aged membranes showed ratios of 27%:23%:15%:35%, closely resembling lipid-free α-syn fibrils but with slightly higher Thr and reduced Gln/Glu/Lys content. Consistent variations were also observed in the 1D 13C CP spectra of the three fibrils (Figure S5I). In lipid-free α-syn fibrils, the spectrum shows stronger signals for Gln/Glu/Lys residues in the 52–55 ppm range and weaker Thr peaks in the 66–69 ppm range compared to the two membrane-associated fibrils. Together, these results demonstrate distinct amino-acid intensity profiles across the three α-syn fibrils, indicating that α-syn fibrils adopt structurally different fibril core domains under varying membrane conditions.
We next used the normalized peak intensities to estimate the fibril core regions by comparing experimental peak ratios with the amino acid composition of different segments of the α-syn sequence. For lipid-free fibrils, the normalized peak intensities closely matched the amino acid distribution of residues M1-L100, suggesting that the fibril core primarily consists of the N-terminal ∼100 residues of α-syn, while G101-A140 remain flexible and do not contribute to the rigid core (Figure S5B,C). In contrast, α-syn fibrils grown with Neuron membranes closely matched the composition of residues G36-A91, whereas fibrils formed with Aged membranes aligned with residues G14-L100 (Figure S5D–G). While these findings support membrane-dependent variations in the fibril core, ssNMR spectra represent averaged signals from all conformations present in a heterogeneous sample. Therefore, additional structural analyses will be necessary to precisely define the fibril core regions, quantitatively assess conformational heterogeneity, and further characterize membrane-induced structural changes.
Distinct Membrane Contacts of α-syn Fibrils with Neuron and Aged Membranes
To investigate the molecular contacts between α-syn fibrils and membranes, we performed 2D 13C-detected 1H–1H spin diffusion NMR experiments on α-syn fibrils grown with Neuron or Aged membranes at an L/P ratio of 10. This experiment correlates the 1H signals from water or lipid acyl chains with 13C signals from the protein by selectively transferring water and lipid 1H signals to the 13C-labeled protein using a 400 μs T2 filter, followed by varying 1H–1H spin diffusion mixing times ranging from 4 to 225 ms. The extent of fibril-membrane and fibril-water interactions can be assessed by comparing the intensities of protein signals transferred from lipids and water. Figures A and C show representative 2D 1H–13C spectra of α-syn fibrils grown with Neuron and Aged membranes, respectively, measured with a 1H–1H spin diffusion mixing time of 100 ms. In both samples, 13C–1H cross peaks between α-syn and lipids, arising from magnetization transfer from lipids to protein, are observed, indicating that both fibrils contact lipid membranes. Notably, α-syn fibrils grown with Neuron membranes exhibited stronger lipid-to-protein signal transfer than those grown with Aged membranes, implying stronger membrane interactions in the former.
5.

Membrane association of α-syn fibrils with Neuron and Aged membranes. (A, C) Representative 2D 13C-detected 1H–1H spin diffusion NMR spectra of α-syn fibrils grown with Neuron membranes (A, green) and with Aged membranes (C, red), overlaid with spectra of fibrils formed with Neuron membranes (green) at an L/P ratio of 10. All spectra were acquired with a 1H–1H spin diffusion mixing time of 100 ms. (B, D) 13C cross sections at 1H chemical shifts of lipid acyl chain (1.3 ppm, orange) and water (5.0 ppm, blue), extracted from 2D 1H–13C spectra of α-syn fibrils grown with Neuron (B) and Aged (D) membranes measured at 1H–1H spin diffusion mixing times of 4 and 100 ms. Lipid cross sections are scaled by a factor of 4 or 8 relative to the water cross sections for clarity. At 100 ms, α-syn fibrils grown with Neuron membranes exhibit higher lipid-to-protein cross peak intensity (7.2%) than those grown with Aged membranes (6.3%), suggesting stronger membrane interactions with Neuron membranes. (E) Lipid-to-protein (solid lines, left) and water-to-protein (dotted lines, right) 1H polarization transfer buildup curves as a function of 1H–1H spin diffusion mixing time. Protein signals transferred from Aged membranes reach saturation after 25 ms of 1H–1H spin diffusion mixing time, whereas signals from Neuron membranes (green) continue to increase and remain stronger throughout the mixing-time range.
To quantitatively compare the membrane association of the two fibrils, we extracted 1D cross sections of 13C protein signals transferred from lipid CH2 (1.3 ppm) and water (5.0 ppm) in the 2D spectra acquired with 1H–1H spin diffusion mixing times of 4 and 100 ms and compared their intensities. At a 4 ms mixing time, both fibrils show a lipid-to-protein cross peak intensity of approximately 6–7% relative to the water-to-protein cross peak intensities (Figures B and D). This ratio is below the typical range observed for membrane-spanning proteins (10–25%), − suggesting that neither fibril type is deeply embedded into the membrane bilayer. At a 100 ms of 1H–1H spin diffusion mixing time, α-syn fibrils grown with Neuron membranes maintain a similar ∼7% lipid-to-protein cross peak intensity relative to water-to-protein cross peaks, indicating that both lipid and water signals increase proportionally with longer 1H–1H spin diffusion mixing times. In contrast, α-syn fibrils grown with Aged membranes show a significant increase in water-to-protein cross peak intensity but not in lipid-to-protein intensity at a 100 ms 1H–1H spin diffusion mixing time, reducing the lipid-to-water cross peak intensity ratio to 1.6%. This suggests that water signal transfer dominates over lipid signal transfer at longer mixing times, implying weaker membrane interactions for α-syn fibrils grown with Aged membranes.
Figure E presents lipid-to-protein and water-to-protein 1H polarization transfer curves for both fibril types as a function of 1H–1H spin diffusion mixing time. The intensities at each 1H–1H spin diffusion mixing time were normalized to the maximum water-to-protein intensity at 100 ms mixing time. The resulting plots reveal that protein signals transferred from Aged membranes plateaued after 25 ms of 1H–1H spin diffusion mixing time, whereas those from Neuron membranes continued to increase. Additionally, the lipid-to-protein signal intensity for α-syn fibrils associated with Aged membrane is significantly lower, approximately three times less, than for fibrils with Neuron membranes. The significantly weak and rapidly saturated lipid-to-protein signals for α-syn fibrils grown with Aged membranes implies that α-syn fibril insertion into the Aged membrane bilayer is limited to a subset of fibrils, or that some broken membrane fragments are incorporated into the fibrils. By contrast, α-syn fibrils grown with Neuron membranes display a steady increase in lipid-to-protein signal intensity up to 225 ms of 1H–1H spin diffusion mixing time (data not shown), indicating that these fibrils not only insert into the lipid bilayer but also remain associated with surrounding Neuron vesicles, as observed in the TEM image (Figure B).
The observed differences in membrane association may stem from stronger binding affinities of Neuron membranes to α-syn monomers or fibrils compared with Aged membranes. Therefore, we measured the binding affinities of α-syn monomers and fibrils to Neuron and Aged membranes. α-syn monomers were incubated with Neuron or Aged membranes for 4 h at 37 °C, after which membrane-bound monomers were separated by ultracentrifugation, and the concentration of free α-syn monomers remaining in the supernatant was quantified. , Although α-syn monomers exhibited comparable binding affinities to Neuron and Aged membranes at an L/P ratio of 10, higher monomer binding affinities were observed for Neuron membranes than Aged membranes at L/P ratios of 5 and 50. (Figure S6A). Next, we examined whether Neuron membranes exhibit stronger binding to lipid-free α-syn fibrils than Aged membranes. Lipid-free α-syn fibrils were incubated with Neuron or Aged membranes at an L/P ratio of 10, and membrane-fibril interactions were assessed by conducting 13C-detected 1H–1H spin diffusion experiments. No fibril–membrane association was detected for either membrane type (Figure S6B,C). Collectively, these findings rule out intrinsic differences in membrane affinity for α-syn fibrils, while indicating that α-syn monomers bind more strongly to Neuron membranes across all L/P ratios. The distinct fibril–membrane associations observed here therefore likely originate from protein–membrane interactions occurring during the early stages of membrane-assisted aggregation.
Conformation-Dependent Intraneuronal Aggregation Properties and Inflammatory Responses
Preformed fibrils (PFFs) were generated by sonicating mature fibrils to examine conformation-dependent pathological effects. PFFs generated from α-syn fibrils grown in the absence of membranes or in the presence of Neuron or Aged membranes are called PFFs, N-PFFs, and Aged-PFFs, respectively. To evaluate conformation-dependent prion-like behavior, 0.4 mol % (monomer equivalent) of PFFs, N-PFFs, or Aged-PFFs was added to a 200 μM solution of monomeric α-syn in the absence of membranes, and fibril formation was monitored using ThT fluorescence. Aggregation kinetics were quantified using t0.1 and t0.5. All PFFs significantly accelerated fibril formation, with N-PFFs and Aged-PFFs showing a trend toward faster fibril formation compared with lipid-free PFFs (Figure S11).
Next, we examined how these polymorphic α-syn fibrils shape disease-relevant phenotypes in dopaminergic neurons, the cell type most affected in PD. − To this end, we used an in vitro cellular model of midbrain tissue by differentiating neuroblastoma cells, which are commonly employed as a dopaminergic cell model in PD research. − Specifically, neuroblastoma cells were introduced into 48-well plates and cultured until they reached confluency (Figure S12A). Neuronal differentiation was then induced through sequential application of two distinct differentiation media formulations designed to drive morphological maturation, as previously described , (Figure S12B). During the early phase of differentiation (Day 2), cells began to extend thin projections (Figure S12C, Day 4), which progressively developed into a dense network of neurite-like structures by Day 12 (Figure S12C, Day 12). Following differentiation, the cells were evaluated for neuronal features by immunostaining for dendritic and axonal markers. This analysis revealed robust expression of microtubule-associated protein 2 (MAP2) and growth-associated protein 43 (GAP43), which serve as markers for dendrites and axons, respectively, confirming that the differentiated neuroblastoma cells had acquired characteristic neuronal phenotypes − (Figure S12D). Their dopaminergic identity was further validated by immunofluorescent staining for tyrosine hydroxylase (TH), an enzyme essential for dopamine biosynthesis and a well-established marker of midbrain dopaminergic neurons , (Figure S12D).
Building upon this neuronal platform, we next investigated how dopaminergic neurons respond to conformationally distinct α-syn PFFs. Specifically, our dopaminergic neuronal cells were treated with PFFs, N-PFFs, and Aged-PFFs to induce pathological features characteristic of PD. To distinguish conformation-dependent effects from those arising from associated lipid components present in N-PFFs and Aged-PFFs, lipid-free PFFs were administered either alone or together with Neuron (PFFs + N-lipid) or Aged membranes (PFFs + Aged-lipid). In addition, α-syn monomers combined with Neuron or Aged membranes (Mono + N-lipid and Mono + Aged-lipid) were included as controls, while untreated cultures served as the negative control. For all treatments, α-syn species were introduced at a concentration of 1.0 μM (monomer equivalent), consistent with prior studies showing that concentrations between 0.25 and 2.0 μM effectively induce PD-associated pathologies in neuronal cultures without causing acute toxicity. − Accordingly, all lipid-containing samples (N-PFFs, Aged-PFFs, PFFs + N-lipid, PFFs + Aged-lipid, Mono + N-lipid, and Mono + Aged-lipid) contained 10 μM of membranes, corresponding to an L/P ratio of 10.
After 3 days of treatment, we investigated whether the polymorphic α-syn PFFs differed in their prion-like capacity to template de novo formation of intracellular α-syn aggregates, a pathological hallmark of PD. As phosphorylation of α-syn at Ser129 (pS129) is a defining molecular signature of the pathogenic α-syn assemblies in synucleinopathies, − we first tested whether distinct PFF conformers differentially promoted pS129 accumulation.
Consistent with their prion-like activity, all PFF treatment groups produced a significant increase in pS129 immunofluorescence compared with untreated controls (Figure A,B). Although these differences did not reach statistical significance, conformationally distinct PFFs showed a trend toward differential levels of pS129 accumulation (Figure B). Notably, Neuron- and Aged membranes alone did not alter pS129 expression, as indicated by the absence of significant changes in Mono + N-lipid and Mono + Aged-lipid groups relative to untreated controls (Figure B). This result was further supported by the observation that addition of Neuron- or Aged membranes to lipid-free PFFs did not affect pS129 levels, as PFFs + N-lipid and PFFs + Aged-lipid exhibited pS129 accumulation similar to lipid-free PFFs alone (Figure B).
6.
In vitro study on the pathological effects of polymorphic α-syn PFFs in dopaminergic neuronal cells. (A) Immunostaining of phosphorylated α-syn (pS129) tended to show varying levels of endogenous α-syn misfolding following treatments with conformationally distinct α-syn PFFs. Neuron- and Aged-membranes did not significantly affect pS129 accumulation. Scale bars, 20 μm. (B) Quantification of pS129 levels in response to distinct α-syn PFF conformations with or without membranes. (C) Immunofluorescence micrographs showing differential formation of intraneuronal α-syn aggregates in response to structurally distinct α-syn PFFs and lipid conditions. Insets show magnified views of α-syn puncta within dopaminergic neurons. Scale bars, 100 μm for main images and 25 μm for insets. (D) Cells treated with distinct α-syn PFFs exhibit differential activation and nuclear translocation of NF-κB. Scale bars, 20 μm. Data show mean ± SD with n = 3. ***P < 0.001, **P < 0.01, *P < 0.05.
Considering that pS129 has been reported to promote α-syn aggregation, ,, we next examined whether distinct α-syn PFF conformers differentially induced intracellular α-syn aggregate formation in our dopaminergic neuronal cells. To assess this, we immunofluorescently labeled intracellular α-syn fibrils as a readout of punctate α-syn structures, which represent small, discrete aggregates of misfolded α-syn protein. Aged-PFFs and lipid-free PFFs produced abundant intraneuronal α-syn puncta in dopaminergic neuronal cells, with Aged-PFFs yielding larger and more intense punctate aggregates (Figure C). This qualitative difference suggests conformational variation among α-syn fibrils that modulates intracellular templating and aggregate expansion (Figure C). In contrast, N-PFF-treated cells exhibited little punctate α-syn staining (Figure C). Notably, PFFs + Aged-lipid treatment exhibited puncta similar to those observed with lipid-free PFFs, while addition of Neuron membranes to PFFs (PFFs + N-lipid) resulted in qualitatively fewer discernible punctate structures (Figure C). Although further analysis is required, these observations suggest that Neuron membranes may suppress punctate α-syn aggregation despite their strong capacity to promote Ser129 phosphorylation. Importantly, control groups with or without lipid components did not exhibit detectable α-syn puncta, indicating that lipid components alone are insufficient to induce α-syn aggregation.
In the subsequent phase of the study, we evaluated whether distinct conformations of α-syn PFFs differentially triggered inflammatory responses in neuronal cells, given increasing evidence that α-syn aggregates contribute to neuroinflammation associated with PD progression. − As a representative readout of neuroinflammatory activation, we analyzed the subcellular localization of nuclear factor-kappa B (NF-κB), a key transcription factor involved in inflammation and cellular stress responses in neurodegeneration. , As the previous aggregation analyses with lipid controls established that lipid components alone do not drive pathological α-syn aggregation, we simplified the experimental design and focused subsequent inflammation analyses on biologically relevant fibril conformers and baseline controls including Aged-PFFs, N-PFFs, lipid-free PFFs, α-syn monomers, and untreated controls. In the absence of pathogenic PFFs, as observed in untreated and monomer-treated cultures, NF-κB was largely retained in the cytoplasm (Figure D), consistent with its inactive state under non-inflammatory conditions. Exposure to N-PFFs or Aged-PFFs, however, induced robust NF-κB nuclear translocation, as evidenced by increased nuclear and decreased cytoplasmic staining (Figure D). Quantitative analysis revealed approximately a 1.5-fold increase in NF-κB nuclear translocation in cultures treated with N-PFFs and Aged-PFFs compared with untreated controls and α-syn monomer-treated cells (Figure D). It should be noted that treatment with PFFs did not alter NF-κB distribution, indicating the conformational specificity of the inflammatory response.
Collectively, these in vitro study results show that Aged-PFFs reproduce several hallmark features of PD, including abnormal α-syn phosphorylation, intracellular fibril aggregation, and NF-κB-mediated neuroinflammation, whereas N-PFFs and lipid-free PFFs induce only partial responses and α-syn monomers do not elicit these effects. These findings suggest that structural variation among α-syn fibril conformers may play a critical role in modulating neuroinflammatory responses, as well as protein misfolding and aggregationkey contributors to dopaminergic neurodegeneration in PD.
Discussion
α-syn membrane binding has been recognized as a critical step in its pathological role, primarily by nucleating aggregation. , To date, extensive studies have examined how lipidsparticularly headgroup compositionaffect α-syn aggregation kinetics, largely using simplified membranes composed of one or two lipid types. ,− ,, However, the influence of lipid fatty acid composition, which primarily governs membrane fluidity and packing, on α-syn aggregation within physiologically relevant neuronal membranes remains underexplored. Notably, aging is associated with a decrease in PUFAs and an increase in monounsaturated fatty acids, representing major alterations in brain lipid composition that reduce membrane fluidity and dynamics. − Here, we provide important insights into how these age-related alterations in membranes influence α-syn fibrils and their pathological effects by using two neuronal membrane models that recapitulate normal and aged lipid compositions.
Our ssNMR results demonstrate that α-syn adopts structurally distinct fibrils when it aggregates in the presence of membranes with different lipid compositions, and the resulting fibrils exhibit distinct membrane-association properties. These membrane-association differences likely arise from variations in membrane–monomer interactions (Figure S6A). Specifically, α-syn fibrils formed with Aged membranes exhibit weaker membrane association compared to those formed with Neuron membranes. To verify that this weaker interaction was not due to the relatively low lipid content at an L/P ratio of 10, we performed 2D 13C-detected 1H–1H spin diffusion experiments on α-syn fibrils grown with Aged membranes at an L/P ratio of 50. The lipid-to-protein signal intensity was comparable to that observed at an L/P ratio of 10 (Figure S7), confirming that the reduced lipid-to-protein signals are not attributable to the lower amount of lipids.
Membranes composed of zwitterionic lipids lacking charged species are known to modulate α-syn binding affinity through lipid packing defects, transient surface gaps between lipid headgroups that expose hydrophobic acyl chains to solvent. The extent of lipid packing defects, which increases with the degree of fatty acid unsaturation, promotes hydrophobic interactions that drive α-syn insertion into the membrane bilayer. , Thus, the enhanced membrane binding of α-syn monomers to Neuron membranes, which contain more unsaturated lipids (POPC and DOPE) compared with Aged membranes (DPPC and POPE), can be attributed to the higher level of lipid packing defects in Neuron membranes. These distinct monomer–membrane interactions may give rise to different fibril structures. Although thorough comparisons will require the development of structural models for each fibril, ssNMR data suggest that the fibril cores span residues 36–91 for α-syn fibrils grown with Neuron membranes and residues 14–100 for those grown with Aged membranes (Figure S5). This indicates that fibrils formed with Neuron membranes retain a longer N-terminal disordered region (residues from 1 to 35) than those formed with Aged membranes (residues from 1 to 13). Because the N-terminal region is known to mediate membrane binding, ,− its stronger affinity for Neuron membranes likely promotes insertion of a longer portion of this region into the lipid bilayer. This insertion may limit its involvement in fibril core formation through protein–protein hydrophobic interactions, resulting in a longer disordered segment compared to fibrils grown with Aged membranes. However, further studies are needed to determine the molecular structures of these fibrils and to investigate residue-specific membrane binding throughout fibril formation, including monomers, oligomers, and fibrils, to gain deeper insight into the structural polymorphisms of membrane-associated fibrils.
To translate membrane-associated α-syn conformers into a patho-physiologically relevant context, we employed an in vitro cell-based platform to investigate the pathological consequences of α-syn polymorphism. Using this interdisciplinary approach, we found that distinct α-syn PFF conformations elicited differential responses in dopaminergic neuronal cells across multiple pathological processes implicated in PD neurodegeneration. Although all α-syn PFF conformations significantly increased Ser129 phosphorylation relative to controls (Figure A,B), their capacities to drive intracellular aggregation differed markedly (Figure C). Specifically, N-PFFs induced robust pS129 accumulation but failed to generate discernible α-syn aggregates, whereas Aged-PFFs and lipid-free PFFs produced prominent intraneuronal aggregates. Notably, Aged-PFFs elicited larger and more abundant α-syn aggregates than N-PFFs and lipid-free PFFs (Figure C). Both N-PFFs and Aged-PFFs retain Neuron and Aged membranes, respectively, raising the possibility that lipid mediated effects could contribute to the observed cellular responses in addition to fibril conformation. To disentangle lipid-driven effects from fibril-driven effects, we therefore incorporated control conditions in which Neuron or Aged membranes were applied to α-syn monomers and to lipid-free PFFs. Using this expanded set of treatments, we examined α-syn phosphorylation and intraneuronal α-syn aggregation (Figure A–C). These experiments showed that lipid components alone do not induce pathological α-syn modification or punctate aggregation. Moreover, Neuron membranes, whether inherently present in N-PFFs or added to lipid-free PFFs (PFFs + N-lipid), do not reproduce the strong aggregate accumulation observed with Aged-PFFs or PFFs + Aged-lipid. Although further validation is needed, these results suggest that Neuron-related lipid components suppress the formation of punctate α-syn aggregates despite strongly promoting Ser129 phosphorylation. This observation may be partly attributed to the higher binding affinity of Neuron membranes for α-syn monomers (Figure S2A), thereby reducing the pool of free monomers available for fibril growth.
Notably, Aged-PFFs induced greater NF-κB nuclear translocation than N-PFFs and lipid-free PFFs (Figure C,D). This enhanced inflammatory activation, together with the abundant intraneuronal aggregates induced by Aged-PFFs, may provide mechanistic insight into clinical differences between young- and late-onset PD progression. Later-onset PD is typically associated with more severe and rapidly progressing symptoms, including motor deficits, cognitive impairment, and greater dopaminergic dysfunction. − Given the central role of neuroinflammation in initiating and accelerating neurodegenerative processes, , the distinct α-syn fibril conformations generated in aged membrane environments may promote more severe and rapid PD progression through enhanced inflammatory responses. However, further studies will be required to determine whether Aged-PFFs specifically drive pathological features characteristic of late-onset PD.
Collectively, these results demonstrate that distinct α-syn PFF conformations differ in their ability to engage multiple pathological pathways. These findings support the idea that membrane-mediated structural diversity of α-syn fibrils contributes to phenotypic heterogeneity in synucleinopathies. ,, Among them, Aged-PFFs emerged as the most pathologically relevant species, as they uniquely triggered the full spectrum of α-syn pathology examined here, including abnormal phosphorylation, intracellular aggregation, and inflammatory activation. This enhanced disease-driving capacity is consistent with their formation under pathologically relevant conditions, in which α-syn monomers interact with aged neuron membrane-related lipid components. Such lipid environments may more closely emulate the subcellular milieu of aging neurons that modulates α-syn aggregation dynamics and fibril conformation in PD, thereby conferring increased pathological potency.
Although our membrane models capture the major physiochemical features of normal and aged neuronal membranes, they do not fully recapitulate the compositional complexity of biological membranes. In particular, our models exclude lipid species that individually account for less than ∼10% of total phospholipids, including PUFAs, ,, due to the simplified four-lipid formulation. Because the most significant age-related changes involve alterations in fatty acid saturation levels largely driven by PUFAs, future studies incorporating these lipid species will be necessary to fully define their contributions to α-syn aggregation and membrane interactions.
Similarly, while our in vitro dopaminergic neuronal model recapitulates several hallmark features of PD pathology, it remains an incomplete representation of the functional complexity of in vivo dopaminergic neurons. In particular, the absence of validated synaptic connectivity may limit its ability to capture interneuronal transmission of α-syn species, a process thought to play a pivotal role in disease progression. − This limitation constrains the extent to which the cellular model can be used to investigate disease mechanisms, as it does not account for the interneuronal spread of pathogenic α-syn, an important aspect of disease progression. To improve the translational relevance of this cellular model, future efforts will need to demonstrate reliable formation of synaptic structures and the occurrence of action potential-mediated synaptic transmission.
Conclusions
In conclusion, our study demonstrates that complex membranes containing cholesterol, phospholipids, and sphingolipids, which mimic neuronal plasma membranes, accelerate α-syn aggregation and generate fibril structures distinct from those formed without membranes. ssNMR data further reveal that age-associated membrane changes in phospholipid fatty acid chains alter both the structures and aggregation kinetics of α-syn fibrils. Moreover, differences in intraneuronal aggregation and inflammatory responses induced by distinct forms of PFFs highlight the critical role of membrane composition in shaping pathogenic protein aggregation. Together, these findings advance our understanding of membrane-mediated, conformation-dependent pathologies and provide insights into the interplay between neurodegenerative protein aggregates and membranes.
Supplementary Material
Acknowledgments
We thank Drs. Ivan Hung and Zhehong Gan at the National High Magnetic Field Laboratory for their assistance with ssNMR experiments. The National High Magnetic Field Laboratory is supported by the National Science Foundation through NSF/DMR-2128556 and the state of Florida. We thank Dr. Yury Gogotsi and AlHourani Jamal from the Department of Materials Science and Engineering at Drexel University for their assistance with DLS measurements. This work was supported by the NIH grant NS139178 to M.L. and J.P.
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acschemneuro.5c00730.
TEM images showing diverse morphologies of α-syn fibrils, proteinase K digestion analysis, full 2D ssNMR spectra of α-syn fibrils, analysis of distinct α-syn fibril cores, membrane binding analysis of α-syn monomers and fibrils, membrane association of α-syn fibrils at L/P = 50, residue-specific membrane interactions of α-syn fibrils, distribution of PFF lengths, calcein membrane leakage assay, conformation-dependent prion-like activities, differentiation of neuroblastoma cells into dopaminergic neurons, and long-term stability of vesicles (PDF)
M.L. and J.P. designed the project. Y.B., A.A., Y.D., and T.O. performed experiments. M.L., J.P., Y.B., and A.A. wrote the manuscript.
The authors declare no competing financial interest.
References
- Calabresi P., Mechelli A., Natale G., Volpicelli-Daley L., Di Lazzaro G., Ghiglieri V.. Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023;14:176. doi: 10.1038/s41419-023-05672-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fusco G., De Simone A., Gopinath T., Vostrikov V., Vendruscolo M., Dobson C. M., Veglia G.. Direct observation of the three regions in alpha-synuclein that determine its membrane-bound behaviour. Nat. Commun. 2014;5:3827. doi: 10.1038/ncomms4827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R., Goedert M.. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839–840. doi: 10.1038/42166. [DOI] [PubMed] [Google Scholar]
- Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M., Goedert M.. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 1998;95:6469–6473. doi: 10.1073/pnas.95.11.6469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wakabayashi K., Yoshimoto M., Tsuji S., Takahashi H.. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 1998;249:180–182. doi: 10.1016/S0304-3940(98)00407-8. [DOI] [PubMed] [Google Scholar]
- Goldstein D. S., Isonaka R., Lamotte G., Kaufmann H.. Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies. Clin Auton Res. 2021;31:677–684. doi: 10.1007/s10286-021-00829-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McKeith I. G., Boeve B. F., Dickson D. W., Halliday G., Taylor J. P., Weintraub D., Aarsland D., Galvin J., Attems J., Ballard C. G.. et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89:88–100. doi: 10.1212/WNL.0000000000004058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krismer F., Wenning G. K.. Multiple system atrophy: insights into a rare and debilitating movement disorder. Nat. Rev. Neurol. 2017;13:232–243. doi: 10.1038/nrneurol.2017.26. [DOI] [PubMed] [Google Scholar]
- Hoppe S. O., Uzunoglu G., Nussbaum-Krammer C.. alpha-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies? Biomolecules. 2021;11:931. doi: 10.3390/biom11070931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mehra S., Gadhe L., Bera R., Sawner A. S., Maji S. K.. Structural and Functional Insights into alpha-Synuclein Fibril Polymorphism. Biomolecules. 2021;11:1419. doi: 10.3390/biom11101419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peng C., Gathagan R. J., Covell D. J., Medellin C., Stieber A., Robinson J. L., Zhang B., Pitkin R. M., Olufemi M. F., Luk K. C.. et al. Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature. 2018;557:558–563. doi: 10.1038/s41586-018-0104-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmitz M., Candelise N., Canaslan S., Altmeppen H. C., Matschke J., Glatzel M., Younas N., Zafar S., Hermann P., Zerr I.. alpha-Synuclein conformers reveal link to clinical heterogeneity of alpha-synucleinopathies. Transl Neurodegener. 2023;12:12. doi: 10.1186/s40035-023-00342-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malfertheiner K., Stefanova N., Heras-Garvin A.. The Concept of alpha-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders. Front Neurol. 2021;12:737195. doi: 10.3389/fneur.2021.737195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sakalauskas A., Ziaunys M., Smirnovas V.. Concentration-dependent polymorphism of insulin amyloid fibrils. PeerJ. 2019;7:e8208. doi: 10.7717/peerj.8208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ziaunys M., Sakalauskas A., Mikalauskaite K., Smirnovas V.. Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration. Int. J. Mol. Sci. 2021;22:12382. doi: 10.3390/ijms222212382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chamachi N. G., Chakrabarty S.. Temperature-Induced Misfolding in Prion Protein: Evidence of Multiple Partially Disordered States Stabilized by Non-Native Hydrogen Bonds. Biochemistry. 2017;56:833–844. doi: 10.1021/acs.biochem.6b01042. [DOI] [PubMed] [Google Scholar]
- Milto K., Michailova K., Smirnovas V.. Elongation of mouse prion protein amyloid-like fibrils: effect of temperature and denaturant concentration. PLoS One. 2014;9:e94469. doi: 10.1371/journal.pone.0094469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tanaka M., Chien P., Yonekura K., Weissman J. S.. Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins. Cell. 2005;121:49–62. doi: 10.1016/j.cell.2005.03.008. [DOI] [PubMed] [Google Scholar]
- Tao Y., Sun Y., Lv S., Xia W., Zhao K., Xu Q., Zhao Q., He L., Le W., Wang Y.. et al. Heparin induces alpha-synuclein to form new fibril polymorphs with attenuated neuropathology. Nat. Commun. 2022;13:4226. doi: 10.1038/s41467-022-31790-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arosio P., Knowles T. P., Linse S.. On the lag phase in amyloid fibril formation. Phys. Chem. Chem. Phys. 2015;17:7606–7618. doi: 10.1039/C4CP05563B. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pancoe S. X., Wang Y. J., Shimogawa M., Perez R. M., Giannakoulias S., Petersson E. J.. Effects of Mutations and Post-Translational Modifications on alpha-Synuclein In Vitro Aggregation. J. Mol. Biol. 2022;434:167859. doi: 10.1016/j.jmb.2022.167859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O’Leary E. I., Jiang Z., Strub M.-P., Lee J. C.. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein. J. Biol. Chem. 2018;293:11195–11205. doi: 10.1074/jbc.RA118.002780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singh B. P., Morris R. J., Kunath T., MacPhee C. E., Horrocks M. H.. Lipid-induced polymorphic amyloid fibril formation by alpha-synuclein. Protein Sci. 2023;32:e4736. doi: 10.1002/pro.4736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kurochka A. S., Yushchenko D. A., Bour P., Shvadchak V. V.. Influence of Lipid Membranes on alpha-Synuclein Aggregation. ACS Chem. Neurosci. 2021;12:825–830. doi: 10.1021/acschemneuro.0c00819. [DOI] [PubMed] [Google Scholar]
- Zhu M., Li J., Fink A. L.. The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation. J. Biol. Chem. 2003;278:40186–40197. doi: 10.1074/jbc.M305326200. [DOI] [PubMed] [Google Scholar]
- Mori A., Imai Y., Hattori N.. Lipids: Key Players That Modulate alpha-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease. Int. J. Mol. Sci. 2020;21:3301. doi: 10.3390/ijms21093301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Makasewicz K., Linse S., Sparr E.. Interplay of alpha-synuclein with Lipid Membranes: Cooperative Adsorption, Membrane Remodeling and Coaggregation. JACS Au. 2024;4:1250–1262. doi: 10.1021/jacsau.3c00579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sharma M., Burre J.. alpha-Synuclein in synaptic function and dysfunction. Trends Neurosci. 2023;46:153–166. doi: 10.1016/j.tins.2022.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burre J., Sharma M., Tsetsenis T., Buchman V., Etherton M. R., Sudhof T. C.. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010;329:1663–1667. doi: 10.1126/science.1195227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dixon C., Mathias N., Zweig R. M., Davis D. A., Gross D. S.. Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast. Genetics. 2005;170:47–59. doi: 10.1534/genetics.104.035493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shahmoradian S. H., Lewis A. J., Genoud C., Hench J., Moors T. E., Navarro P. P., Castano-Diez D., Schweighauser G., Graff-Meyer A., Goldie K. N.. et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 2019;22:1099–1109. doi: 10.1038/s41593-019-0423-2. [DOI] [PubMed] [Google Scholar]
- Emamzadeh F. N.. Alpha-synuclein structure, functions, and interactions. J. Res. Med. Sci. 2016;21:29. doi: 10.4103/1735-1995.181989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ruf V. C., Nübling G. S., Willikens S., Shi S., Schmidt F., Levin J., Bötzel K., Kamp F., Giese A.. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements. ACS Chem. Neurosci. 2019;10:1649–1659. doi: 10.1021/acschemneuro.8b00579. [DOI] [PubMed] [Google Scholar]
- Galvagnion C.. The Role of Lipids Interacting with alpha-Synuclein in the Pathogenesis of Parkinson’s Disease. J. Parkinsons Dis. 2017;7:433–450. doi: 10.3233/JPD-171103. [DOI] [PubMed] [Google Scholar]
- Galvagnion C., Brown J. W., Ouberai M. M., Flagmeier P., Vendruscolo M., Buell A. K., Sparr E., Dobson C. M.. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of alpha-synuclein. Proc. Natl. Acad. Sci. U. S. A. 2016;113:7065–7070. doi: 10.1073/pnas.1601899113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Galvagnion C., Buell A. K., Meisl G., Michaels T. C., Vendruscolo M., Knowles T. P., Dobson C. M.. Lipid vesicles trigger alpha-synuclein aggregation by stimulating primary nucleation. Nat. Chem. Biol. 2015;11:229–234. doi: 10.1038/nchembio.1750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu M., Fink A. L.. Lipid binding inhibits alpha-synuclein fibril formation. J. Biol. Chem. 2003;278:16873–16877. doi: 10.1074/jbc.M210136200. [DOI] [PubMed] [Google Scholar]
- Gaspar R., Pallbo J., Weininger U., Linse S., Sparr E.. Reprint of ″Ganglioside lipids accelerate alpha-synuclein amyloid formation″. Biochim Biophys Acta Proteins Proteom. 2019;1867:508–518. doi: 10.1016/j.bbapap.2019.02.003. [DOI] [PubMed] [Google Scholar]
- Watt K. J. C., Meade R. M., Williams R. J., Mason J. M.. Anionic lipid vesicles have differential effects on the aggregation of early onset-associated alpha-synuclein missense mutants. J. Biol. Chem. 2022;298:102565. doi: 10.1016/j.jbc.2022.102565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O’Leary E. I., Lee J. C.. Interplay between alpha-synuclein amyloid formation and membrane structure. Biochim Biophys Acta Proteins Proteom. 2019;1867:483–491. doi: 10.1016/j.bbapap.2018.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Terakawa M. S., Lee Y. H., Kinoshita M., Lin Y., Sugiki T., Fukui N., Ikenoue T., Kawata Y., Goto Y.. Membrane-induced initial structure of alpha-synuclein control its amyloidogenesis on model membranes. Biochim Biophys Acta Biomembr. 2018;1860:757–766. doi: 10.1016/j.bbamem.2017.12.011. [DOI] [PubMed] [Google Scholar]
- Jiang Z., de Messieres M., Lee J. C.. Membrane remodeling by alpha-synuclein and effects on amyloid formation. J. Am. Chem. Soc. 2013;135:15970–15973. doi: 10.1021/ja405993r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dasari A. K. R., Dillard L., Yi S., Viverette E., Hojjatian A., Sengupta U., Kayed R., Taylor K. A., Borgnia M. J., Lim K. H.. Untwisted alpha-Synuclein Filaments Formed in the Presence of Lipid Vesicles. Biochemistry. 2022;61:1766–1773. doi: 10.1021/acs.biochem.2c00283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frieg B., Antonschmidt L., Dienemann C., Geraets J. A., Najbauer E. E., Matthes D., de Groot B. L., Andreas L. B., Becker S., Griesinger C., Schroder G. F.. The 3D structure of lipidic fibrils of alpha-synuclein. Nat. Commun. 2022;13:6810. doi: 10.1038/s41467-022-34552-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dou T., Matveyenka M., Kurouski D.. Elucidation of Secondary Structure and Toxicity of alpha-Synuclein Oligomers and Fibrils Grown in the Presence of Phosphatidylcholine and Phosphatidylserine. ACS Chem. Neurosci. 2023;14:3183–3191. doi: 10.1021/acschemneuro.3c00314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhaliazka K., Ali A., Kurouski D.. Phospholipids and Cholesterol Determine Molecular Mechanisms of Cytotoxicity of alpha-Synuclein Oligomers and Fibrils. ACS Chem. Neurosci. 2024;15:371–381. doi: 10.1021/acschemneuro.3c00671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Matveyenka M., Zhaliazka K., Kurouski D.. Unsaturated fatty acids uniquely alter aggregation rate of alpha-synuclein and insulin and change the secondary structure and toxicity of amyloid aggregates formed in their presence. FASEB J. 2023;37:e22972. doi: 10.1096/fj.202300003R. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Antonschmidt L., Dervisoglu R., Sant V., Tekwani Movellan K., Mey I., Riedel D., Steinem C., Becker S., Andreas L. B., Griesinger C.. Insights into the molecular mechanism of amyloid filament formation: Segmental folding of alpha-synuclein on lipid membranes. Sci. Adv. 2021;7:eabg2174. doi: 10.1126/sciadv.abg2174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norton W. T., Abe T., Poduslo S. E., DeVries G. H.. The lipid composition of isolated brain cells and axons. J. Neurosci Res. 1975;1:57–75. doi: 10.1002/jnr.490010106. [DOI] [PubMed] [Google Scholar]
- Giusto N. M., Salvador G. A., Castagnet P. I., Pasquaré S. J., Ilincheta de Boschero M. G.. Age-associated changes in central nervous system glycerolipid composition and metabolism. Neurochem. Res. 2002;27:1513–1523. doi: 10.1023/A:1021604623208. [DOI] [PubMed] [Google Scholar]
- Mota-Martorell N., Andres-Benito P., Martin-Gari M., Galo-Licona J. D., Sol J., Fernandez-Bernal A., Portero-Otin M., Ferrer I., Jove M., Pamplona R.. Selective brain regional changes in lipid profile with human aging. Geroscience. 2022;44:763–783. doi: 10.1007/s11357-022-00527-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pollard A. K., Ortori C. A., Stoger R., Barrett D. A., Chakrabarti L.. Mouse mitochondrial lipid composition is defined by age in brain and muscle. Aging (Albany NY) 2017;9:986–998. doi: 10.18632/aging.101204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fitzner D., Bader J. M., Penkert H., Bergner C. G., Su M., Weil M. T., Surma M. A., Mann M., Klose C., Simons M.. Cell-Type- and Brain-Region-Resolved Mouse Brain Lipidome. Cell Rep. 2020;32:108132. doi: 10.1016/j.celrep.2020.108132. [DOI] [PubMed] [Google Scholar]
- Tamai Y., Matsukawa S., Satake M.. Lipid composition of nerve cell perikarya. Brain Res. 1971;26:149–157. doi: 10.1016/0006-8993(71)90550-6. [DOI] [Google Scholar]
- Ulmann L., Mimouni V., Roux S., Porsolt R., Poisson J. P.. Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. Prostaglandins Leukot Essent Fatty Acids. 2001;64:189–195. doi: 10.1054/plef.2001.0260. [DOI] [PubMed] [Google Scholar]
- Lopez G. H., Ilincheta de Boschero M. G., Castagnet P. I., Giusto N. M.. Age-associated changes in the content and fatty acid composition of brain glycerophospholipids. Comp Biochem Physiol B Biochem Mol. Biol. 1995;112:331–343. doi: 10.1016/0305-0491(95)00079-8. [DOI] [PubMed] [Google Scholar]
- Stephens A. D., Matak-Vinkovic D., Fernandez-Villegas A., Kaminski Schierle G. S.. Purification of Recombinant alpha-synuclein: A Comparison of Commonly Used Protocols. Biochemistry. 2020;59:4563–4572. doi: 10.1021/acs.biochem.0c00725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takegoshi K., Nakamura S., Terao T.. 13C-1H dipolar-assisted rotational resonance in magic-angle spinning NMR. Chem. Phys. Lett. 2001;344:631–637. doi: 10.1016/S0009-2614(01)00791-6. [DOI] [Google Scholar]
- Morcombe C. R., Gaponenko V., Byrd R. A., Zilm K. W.. Diluting abundant spins by isotope edited radio frequency field assisted diffusion. J. Am. Chem. Soc. 2004;126:7196–7197. doi: 10.1021/ja047919t. [DOI] [PubMed] [Google Scholar]
- Huster D., Yao X., Hong M.. Membrane protein topology probed by (1)H spin diffusion from lipids using solid-state NMR spectroscopy. J. Am. Chem. Soc. 2002;124:874–883. doi: 10.1021/ja017001r. [DOI] [PubMed] [Google Scholar]
- Kumashiro K. K., Schmidt-Rohr K., Murphy O. J., Ouellette K. L., Cramer W. A., Thompson L. K.. A Novel Tool for Probing Membrane Protein Structure:Solid-State NMR with Proton Spin Diffusion and X-Nucleus Detection. J. Am. Chem. Soc. 1998;120:5043–5051. doi: 10.1021/ja972655e. [DOI] [Google Scholar]
- El Mammeri N., Duan P., Hong M.. Pseudo-Phosphorylated Tau Forms Paired Helical Filaments in the Presence of High-Curvature Cholesterol-Containing Lipid Membranes. J. Am. Chem. Soc. 2025;147:2510–2522. doi: 10.1021/jacs.4c13772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dutta S., Watson B. G., Mattoo S., Rochet J. C.. Calcein Release Assay to Measure Membrane Permeabilization by Recombinant Alpha-Synuclein. Bio Protoc. 2020;10:e3690. doi: 10.21769/BioProtoc.3690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Georgieva E. R., Ramlall T. F., Borbat P. P., Freed J. H., Eliezer D.. Membrane-bound alpha-synuclein forms an extended helix: long-distance pulsed ESR measurements using vesicles, bicelles, and rodlike micelles. J. Am. Chem. Soc. 2008;130:12856–12857. doi: 10.1021/ja804517m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ferreon A. C., Gambin Y., Lemke E. A., Deniz A. A.. Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence. Proc. Natl. Acad. Sci. U. S. A. 2009;106:5645–5650. doi: 10.1073/pnas.0809232106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ulmer T. S., Bax A.. Comparison of structure and dynamics of micelle-bound human alpha-synuclein and Parkinson disease variants. J. Biol. Chem. 2005;280:43179–43187. doi: 10.1074/jbc.M507624200. [DOI] [PubMed] [Google Scholar]
- Kushnirov V. V., Dergalev A. A., Alexandrov A. I.. Proteinase K resistant cores of prions and amyloids. Prion. 2020;14:11–19. doi: 10.1080/19336896.2019.1704612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guo J. L., Covell D. J., Daniels J. P., Iba M., Stieber A., Zhang B., Riddle D. M., Kwong L. K., Xu Y., Trojanowski J. Q., Lee V. M.. Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell. 2013;154:103–117. doi: 10.1016/j.cell.2013.05.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silva C. J., Vazquez-Fernandez E., Onisko B., Requena J. R.. Proteinase K and the structure of PrPSc: The good, the bad and the ugly. Virus Res. 2015;207:120–126. doi: 10.1016/j.virusres.2015.03.008. [DOI] [PubMed] [Google Scholar]
- Tanaka G., Yamanaka T., Furukawa Y., Kajimura N., Mitsuoka K., Nukina N.. Sequence- and seed-structure-dependent polymorphic fibrils of alpha-synuclein. Biochim Biophys Acta Mol. Basis Dis. 2019;1865:1410–1420. doi: 10.1016/j.bbadis.2019.02.013. [DOI] [PubMed] [Google Scholar]
- Pines A., Gibby M. G., Waugh J. S.. Proton-enhanced NMR of dilute spins in solids. J. Chem. Phys. 1973;59:569–590. doi: 10.1063/1.1680061. [DOI] [Google Scholar]
- Bennett A. E., Rienstra C. M., Auger M., Lakshmi K. V., Griffin R. G.. Heteronuclear decoupling in rotating solids. J. Chem. Phys. 1995;103:6951–6958. doi: 10.1063/1.470372. [DOI] [Google Scholar]
- Murray D. T., Kato M., Lin Y., Thurber K. R., Hung I., McKnight S. L., Tycko R.. Structure of FUS Protein Fibrils and Its Relevance to Self-Assembly and Phase Separation of Low-Complexity Domains. Cell. 2017;171:615–627. doi: 10.1016/j.cell.2017.08.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee M., Ghosh U., Thurber K. R., Kato M., Tycko R.. Molecular structure and interactions within amyloid-like fibrils formed by a low-complexity protein sequence from FUS. Nat. Commun. 2020;11:5735. doi: 10.1038/s41467-020-19512-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heise H., Hoyer W., Becker S., Andronesi O. C., Riedel D., Baldus M.. Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc. Natl. Acad. Sci. U. S. A. 2005;102:15871–15876. doi: 10.1073/pnas.0506109102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paravastu A. K., Leapman R. D., Yau W. M., Tycko R.. Molecular structural basis for polymorphism in Alzheimer’s beta-amyloid fibrils. Proc. Natl. Acad. Sci. U. S. A. 2008;105:18349–18354. doi: 10.1073/pnas.0806270105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kwon B., Lee M., Waring A. J., Hong M.. Oligomeric Structure and Three-Dimensional Fold of the HIV gp41 Membrane-Proximal External Region and Transmembrane Domain in Phospholipid Bilayers. J. Am. Chem. Soc. 2018;140:8246–8259. doi: 10.1021/jacs.8b04010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee M., Morgan C. A., Hong M.. Fully hydrophobic HIV gp41 adopts a hemifusion-like conformation in phospholipid bilayers. J. Biol. Chem. 2019;294:14732–14744. doi: 10.1074/jbc.RA119.009542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yao H., Lee M. W., Waring A. J., Wong G. C., Hong M.. Viral fusion protein transmembrane domain adopts beta-strand structure to facilitate membrane topological changes for virus-cell fusion. Proc. Natl. Acad. Sci. U. S. A. 2015;112:10926–10931. doi: 10.1073/pnas.1501430112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qiang W., Kengwerere M. K., Zhao W., Scott F. J., Wutoh-Hughes X., Wang T., Mentink-Vigier F.. Heterotypic Interactions between the 40- and 42-Residue Isoforms of beta-Amyloid Peptides on Lipid Bilayer Surfaces. ACS Chem. Neurosci. 2023;14:4153–4162. doi: 10.1021/acschemneuro.3c00523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheng Q., Hu Z. W., Doherty K. E., Tobin-Miyaji Y. J., Qiang W.. The on-fibrillation-pathway membrane content leakage and off-fibrillation-pathway lipid mixing induced by 40-residue beta-amyloid peptides in biologically relevant model liposomes. Biochim Biophys Acta Biomembr. 2018;1860:1670–1680. doi: 10.1016/j.bbamem.2018.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kamath T., Abdulraouf A., Burris S. J., Langlieb J., Gazestani V., Nadaf N. M., Balderrama K., Vanderburg C., Macosko E. Z.. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease. Nat. Neurosci. 2022;25:588–595. doi: 10.1038/s41593-022-01061-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Michel P. P., Hirsch E. C., Hunot S.. Understanding Dopaminergic Cell Death Pathways in Parkinson Disease. Neuron. 2016;90:675–691. doi: 10.1016/j.neuron.2016.03.038. [DOI] [PubMed] [Google Scholar]
- Lo Bianco C., Ridet J. L., Schneider B. L., Deglon N., Aebischer P.. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson’s disease. Proc. Natl. Acad. Sci. U. S. A. 2002;99:10813–10818. doi: 10.1073/pnas.152339799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ioghen O. C., Ceafalan L. C., Popescu B. O.. SH-SY5Y Cell Line In Vitro Models for Parkinson Disease Research-Old Practice for New Trends. J. Integr Neurosci. 2023;22:20. doi: 10.31083/j.jin2201020. [DOI] [PubMed] [Google Scholar]
- Xicoy H., Wieringa B., Martens G. J.. The SH-SY5Y cell line in Parkinson’s disease research: a systematic review. Mol. Neurodegener. 2017;12:10. doi: 10.1186/s13024-017-0149-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xie H. R., Hu L. S., Li G. Y.. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson’s disease. Chin Med. J. 2010;123:1086–1092. doi: 10.3760/cma.j.issn.0366-6999.2010.08.021. [DOI] [PubMed] [Google Scholar]
- Alim A., Baek Y., Lee M., Paek J.. Microengineering of the capillary interface of midbrain dopaminergic neurons to study Parkinson’s disease vascular alterations. Comms. Eng. 2026 doi: 10.1038/s44172-025-00581-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dravid A., Raos B., Svirskis D., O’Carroll S. J.. Optimised techniques for high-throughput screening of differentiated SH-SY5Y cells and application for neurite outgrowth assays. Sci. Rep. 2021;11:23935. doi: 10.1038/s41598-021-03442-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shipley M. M., Mangold C. A., Szpara M. L.. Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line. J. Vis Exp. 2016:53193. doi: 10.3791/53193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Soltani M. H., Pichardo R., Song Z., Sangha N., Camacho F., Satyamoorthy K., Sangueza O. P., Setaluri V.. Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma. Am. J. Pathol. 2005;166:1841–1850. doi: 10.1016/S0002-9440(10)62493-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harada A., Teng J., Takei Y., Oguchi K., Hirokawa N.. MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. J. Cell Biol. 2002;158:541–549. doi: 10.1083/jcb.200110134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Okada M., Kawagoe Y., Sato Y., Nozumi M., Ishikawa Y., Tamada A., Yamazaki H., Sekino Y., Kanemura Y., Shinmyo Y.. et al. Phosphorylation of GAP-43 T172 is a molecular marker of growing axons in a wide range of mammals including primates. Mol. Brain. 2021;14:66. doi: 10.1186/s13041-021-00755-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denny J. B.. Molecular mechanisms, biological actions, and neuropharmacology of the growth-associated protein GAP-43. Curr. Neuropharmacol. 2006;4:293–304. doi: 10.2174/157015906778520782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Skene J. H.. Axonal growth-associated proteins. Annu. Rev. Neurosci. 1989;12:127–156. doi: 10.1146/annurev.ne.12.030189.001015. [DOI] [PubMed] [Google Scholar]
- Weihe E., Depboylu C., Schütz B., Schäfer M. K. H., Eiden L. E.. Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression. Cell Mol. Neurobiol. 2006;26:657–678. doi: 10.1007/s10571-006-9053-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- B. White R., G. Thomas M.. Moving beyond tyrosine hydroxylase to define dopaminergic neurons for use in cell replacement therapies for Parkinson’s disease. CNS Neurol. Disord. Drug Targets. 2012;11:340–349. doi: 10.2174/187152712800792758. [DOI] [PubMed] [Google Scholar]
- Kim B. J., Noh H. R., Jeon H., Park S. M.. Monitoring α-synuclein Aggregation Induced by Preformed α-synuclein Fibrils in an In Vitro Model System. Exp Neurobiol. 2023;32:147–156. doi: 10.5607/en23007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cascella R., Chen S. W., Bigi A., Camino J. D., Xu C. K., Dobson C. M., Chiti F., Cremades N., Cecchi C.. The release of toxic oligomers from alpha-synuclein fibrils induces dysfunction in neuronal cells. Nat. Commun. 2021;12:1814. doi: 10.1038/s41467-021-21937-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bigi A., Ermini E., Chen S. W., Cascella R., Cecchi C.. Exploring the Release of Toxic Oligomers from α-Synuclein Fibrils with Antibodies and STED Microscopy. Life (Basel) 2021;11:431. doi: 10.3390/life11050431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feng C., Flores M., Dhoj C., Garcia A., Belleca S., Abbas D. A., Parres-Gold J., Anguiano A., Porter E., Wang Y.. Observation of α-Synuclein Preformed Fibrils Interacting with SH-SY5Y Neuroblastoma Cell Membranes Using Scanning Ion Conductance Microscopy. ACS Chem. Neurosci. 2022;13:3547–3553. doi: 10.1021/acschemneuro.2c00478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feller B., Fallon A., Luo W., Nguyen P. T., Shlaifer I., Lee A. K., Chofflet N., Yi N., Khaled H., Karkout S.. et al. α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization. Cells. 2023;12:1083. doi: 10.3390/cells12071083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghanem S. S., Majbour N. K., Vaikath N. N., Ardah M. T., Erskine D., Jensen N. M., Fayyad M., Sudhakaran I. P., Vasili E., Melachroinou K.. et al. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proc. Natl. Acad. Sci. U. S. A. 2022;119:e2109617119. doi: 10.1073/pnas.2109617119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guan Y., Zhao X., Liu F., Yan S., Wang Y., Du C., Cui X., Li R., Zhang C. X.. Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein. Front Cell Neurosci. 2020;14:159. doi: 10.3389/fncel.2020.00159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Y., Shi M., Chung K. A., Zabetian C. P., Leverenz J. B., Berg D., Srulijes K., Trojanowski J. Q., Lee V. M., Siderowf A. D.. et al. Phosphorylated α-synuclein in Parkinson’s disease. Sci. Transl Med. 2012;4:121ra120. doi: 10.1126/scitranslmed.3002566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen L., Periquet M., Wang X., Negro A., McLean P. J., Hyman B. T., Feany M. B.. Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J. Clin Invest. 2009;119:3257–3265. doi: 10.1172/JCI39088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M. S., Shen J., Takio K., Iwatsubo T.. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 2002;4:160–164. doi: 10.1038/ncb748. [DOI] [PubMed] [Google Scholar]
- Smith W. W., Margolis R. L., Li X., Troncoso J. C., Lee M. K., Dawson V. L., Dawson T. M., Iwatsubo T., Ross C. A.. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. J. Neurosci. 2005;25:5544–5552. doi: 10.1523/JNEUROSCI.0482-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lema Tomé C. M., Tyson T., Rey N. L., Grathwohl S., Britschgi M., Brundin P.. Inflammation and α-synuclein’s prion-like behavior in Parkinson’s disease--is there a link? Mol. Neurobiol. 2013;47:561–574. doi: 10.1007/s12035-012-8267-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cardinale A., Calabrese V., de Iure A., Picconi B.. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease. Int. J. Mol. Sci. 2021;22:6517. doi: 10.3390/ijms22126517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gao H. M., Kotzbauer P. T., Uryu K., Leight S., Trojanowski J. Q., Lee V. M.. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J. Neurosci. 2008;28:7687–7698. doi: 10.1523/JNEUROSCI.0143-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flood P. M., Qian L., Peterson L. J., Zhang F., Shi J. S., Gao H. M., Hong J. S.. Transcriptional Factor NF-kappaB as a Target for Therapy in Parkinson’s Disease. Parkinsons Dis. 2011;2011:216298. doi: 10.4061/2011/216298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singh S. S., Rai S. N., Birla H., Zahra W., Rathore A. S., Singh S. P.. NF-κB-Mediated Neuroinflammation in Parkinson’s Disease and Potential Therapeutic Effect of Polyphenols. Neurotox Res. 2020;37:491–507. doi: 10.1007/s12640-019-00147-2. [DOI] [PubMed] [Google Scholar]
- Shih R. H., Wang C. Y., Yang C. M.. NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review. Front Mol. Neurosci. 2015;8:77. doi: 10.3389/fnmol.2015.00077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grey M., Dunning C. J., Gaspar R., Grey C., Brundin P., Sparr E., Linse S.. Acceleration of alpha-synuclein aggregation by exosomes. J. Biol. Chem. 2015;290:2969–2982. doi: 10.1074/jbc.M114.585703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bigay J., Antonny B.. Curvature, lipid packing, and electrostatics of membrane organelles: defining cellular territories in determining specificity. Dev Cell. 2012;23:886–895. doi: 10.1016/j.devcel.2012.10.009. [DOI] [PubMed] [Google Scholar]
- Johnson D. H., Kou O. H., White J. M., Ramirez S. Y., Margaritakis A., Chung P. J., Jaeger V. W., Zeno W. F.. Lipid packing defects are necessary and sufficient for membrane binding of alpha-synuclein. Commun. Biol. 2025;8:1179. doi: 10.1038/s42003-025-08622-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tuttle M. D., Comellas G., Nieuwkoop A. J., Covell D. J., Berthold D. A., Kloepper K. D., Courtney J. M., Kim J. K., Barclay A. M., Kendall A.. et al. Solid-state NMR structure of a pathogenic fibril of full-length human alpha-synuclein. Nat. Struct Mol. Biol. 2016;23:409–415. doi: 10.1038/nsmb.3194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Middleton E. R., Rhoades E.. Effects of curvature and composition on alpha-synuclein binding to lipid vesicles. Biophys. J. 2010;99:2279–2288. doi: 10.1016/j.bpj.2010.07.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jo E., Fuller N., Rand R. P., St George-Hyslop P., Fraser P. E.. Defective membrane interactions of familial Parkinson’s disease mutant A30P alpha-synuclein. J. Mol. Biol. 2002;315:799–807. doi: 10.1006/jmbi.2001.5269. [DOI] [PubMed] [Google Scholar]
- Pagano G., Ferrara N., Brooks D. J., Pavese N.. Age at onset and Parkinson disease phenotype. Neurology. 2016;86:1400–1407. doi: 10.1212/WNL.0000000000002461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levy G.. The relationship of Parkinson disease with aging. Arch Neurol. 2007;64:1242–1246. doi: 10.1001/archneur.64.9.1242. [DOI] [PubMed] [Google Scholar]
- Raket L. L., Oudin Astrom D., Norlin J. M., Kellerborg K., Martinez-Martin P., Odin P.. Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease. Sci. Rep. 2022;12:526. doi: 10.1038/s41598-021-04356-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ransohoff R. M.. How neuroinflammation contributes to neurodegeneration. Science. 2016;353:777–783. doi: 10.1126/science.aag2590. [DOI] [PubMed] [Google Scholar]
- Qin X. Y., Zhang S. P., Cao C., Loh Y. P., Cheng Y.. Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis. JAMA Neurol. 2016;73:1316–1324. doi: 10.1001/jamaneurol.2016.2742. [DOI] [PubMed] [Google Scholar]
- Spillantini M. G., Goedert M.. The alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Ann. N.Y. Acad. Sci. 2000;920:16–27. doi: 10.1111/j.1749-6632.2000.tb06900.x. [DOI] [PubMed] [Google Scholar]
- Melki R.. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases. J. Parkinsons Dis. 2015;5:217–227. doi: 10.3233/JPD-150543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choi J., Yin T., Shinozaki K., Lampe J. W., Stevens J. F., Becker L. B., Kim J.. Comprehensive analysis of phospholipids in the brain, heart, kidney, and liver: brain phospholipids are least enriched with polyunsaturated fatty acids. Mol. Cell. Biochem. 2018;442:187–201. doi: 10.1007/s11010-017-3203-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martinez M., Mougan I.. Fatty acid composition of human brain phospholipids during normal development. J. Neurochem. 1998;71:2528–2533. doi: 10.1046/j.1471-4159.1998.71062528.x. [DOI] [PubMed] [Google Scholar]
- Rey N. L., Steiner J. A., Maroof N., Luk K. C., Madaj Z., Trojanowski J. Q., Lee V. M., Brundin P.. Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease. J. Exp Med. 2016;213:1759–1778. doi: 10.1084/jem.20160368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mezias C., Rey N., Brundin P., Raj A.. Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation. Neurobiol Dis. 2020;134:104623. doi: 10.1016/j.nbd.2019.104623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kulkarni A. S., Burns M. R., Brundin P., Wesson D. W.. Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease. Brain Commun. 2022;4:fcac165. doi: 10.1093/braincomms/fcac165. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



